Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:cd47 antagonist alx148'
(id=8833935 ; fe=en:cd47 antagonist alx148 ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=8103 creation date=2017-08-31 touchdate=2025-07-25 10:50:24.000)
≈ 355 relations sortantes

  1. en:cd47 antagonist alx148 -- r_associated #0: 43 / 1 -> en:ep4 receptor antagonist aat-007
    n1=en:cd47 antagonist alx148 | n2=en:ep4 receptor antagonist aat-007 | rel=r_associated | relid=0 | w=43
  2. en:cd47 antagonist alx148 -- r_associated #0: 43 / 1 -> en:mitoxantrone
    n1=en:cd47 antagonist alx148 | n2=en:mitoxantrone | rel=r_associated | relid=0 | w=43
  3. en:cd47 antagonist alx148 -- r_associated #0: 43 / 1 -> en:oxphos inhibitor vlx600
    n1=en:cd47 antagonist alx148 | n2=en:oxphos inhibitor vlx600 | rel=r_associated | relid=0 | w=43
  4. en:cd47 antagonist alx148 -- r_associated #0: 43 / 1 -> en:synthetic antiandrogen
    n1=en:cd47 antagonist alx148 | n2=en:synthetic antiandrogen | rel=r_associated | relid=0 | w=43
  5. en:cd47 antagonist alx148 -- r_associated #0: 42 / 0.977 -> en:nanocell-encapsulated mir-16-based microrna mimic
    n1=en:cd47 antagonist alx148 | n2=en:nanocell-encapsulated mir-16-based microrna mimic | rel=r_associated | relid=0 | w=42
  6. en:cd47 antagonist alx148 -- r_associated #0: 42 / 0.977 -> en:vorinostat
    n1=en:cd47 antagonist alx148 | n2=en:vorinostat | rel=r_associated | relid=0 | w=42
  7. en:cd47 antagonist alx148 -- r_associated #0: 41 / 0.953 -> en:panobinostat
    n1=en:cd47 antagonist alx148 | n2=en:panobinostat | rel=r_associated | relid=0 | w=41
  8. en:cd47 antagonist alx148 -- r_associated #0: 40 / 0.93 -> en:chlorotoxin [131i]
    n1=en:cd47 antagonist alx148 | n2=en:chlorotoxin [131i] | rel=r_associated | relid=0 | w=40
  9. en:cd47 antagonist alx148 -- r_associated #0: 39 / 0.907 -> en:maltose tetrapalmitate
    n1=en:cd47 antagonist alx148 | n2=en:maltose tetrapalmitate | rel=r_associated | relid=0 | w=39
  10. en:cd47 antagonist alx148 -- r_associated #0: 38 / 0.884 -> en:antineoplastic agent trx-818
    n1=en:cd47 antagonist alx148 | n2=en:antineoplastic agent trx-818 | rel=r_associated | relid=0 | w=38
  11. en:cd47 antagonist alx148 -- r_associated #0: 38 / 0.884 -> en:bevacizumab
    n1=en:cd47 antagonist alx148 | n2=en:bevacizumab | rel=r_associated | relid=0 | w=38
  12. en:cd47 antagonist alx148 -- r_associated #0: 38 / 0.884 -> en:cedefingol
    n1=en:cd47 antagonist alx148 | n2=en:cedefingol | rel=r_associated | relid=0 | w=38
  13. en:cd47 antagonist alx148 -- r_associated #0: 38 / 0.884 -> en:etidronate-cytarabine conjugate mbc-11
    n1=en:cd47 antagonist alx148 | n2=en:etidronate-cytarabine conjugate mbc-11 | rel=r_associated | relid=0 | w=38
  14. en:cd47 antagonist alx148 -- r_associated #0: 38 / 0.884 -> en:pv-10
    n1=en:cd47 antagonist alx148 | n2=en:pv-10 | rel=r_associated | relid=0 | w=38
  15. en:cd47 antagonist alx148 -- r_associated #0: 37 / 0.86 -> en:bryostatin 1
    n1=en:cd47 antagonist alx148 | n2=en:bryostatin 1 | rel=r_associated | relid=0 | w=37
  16. en:cd47 antagonist alx148 -- r_associated #0: 36 / 0.837 -> en:beta-elemene
    n1=en:cd47 antagonist alx148 | n2=en:beta-elemene | rel=r_associated | relid=0 | w=36
  17. en:cd47 antagonist alx148 -- r_associated #0: 36 / 0.837 -> en:braf inhibitor
    n1=en:cd47 antagonist alx148 | n2=en:braf inhibitor | rel=r_associated | relid=0 | w=36
  18. en:cd47 antagonist alx148 -- r_associated #0: 36 / 0.837 -> en:calusterone
    n1=en:cd47 antagonist alx148 | n2=en:calusterone | rel=r_associated | relid=0 | w=36
  19. en:cd47 antagonist alx148 -- r_associated #0: 36 / 0.837 -> en:daratumumab
    n1=en:cd47 antagonist alx148 | n2=en:daratumumab | rel=r_associated | relid=0 | w=36
  20. en:cd47 antagonist alx148 -- r_associated #0: 36 / 0.837 -> en:gamboge resin extract tsb-9-w1
    n1=en:cd47 antagonist alx148 | n2=en:gamboge resin extract tsb-9-w1 | rel=r_associated | relid=0 | w=36
  21. en:cd47 antagonist alx148 -- r_associated #0: 36 / 0.837 -> en:topoisomerase ii inhibitors
    n1=en:cd47 antagonist alx148 | n2=en:topoisomerase ii inhibitors | rel=r_associated | relid=0 | w=36
  22. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:acivicin
    n1=en:cd47 antagonist alx148 | n2=en:acivicin | rel=r_associated | relid=0 | w=35
  23. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:alpha-gal glycosphingolipids
    n1=en:cd47 antagonist alx148 | n2=en:alpha-gal glycosphingolipids | rel=r_associated | relid=0 | w=35
  24. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:angiogenesis inhibitor
    n1=en:cd47 antagonist alx148 | n2=en:angiogenesis inhibitor | rel=r_associated | relid=0 | w=35
  25. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:antineoplastic hormonal/endocrine agent
    n1=en:cd47 antagonist alx148 | n2=en:antineoplastic hormonal/endocrine agent | rel=r_associated | relid=0 | w=35
  26. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:antineoplastic radiopharmaceutical agent
    n1=en:cd47 antagonist alx148 | n2=en:antineoplastic radiopharmaceutical agent | rel=r_associated | relid=0 | w=35
  27. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:antineoplastic vinca alkaloid
    n1=en:cd47 antagonist alx148 | n2=en:antineoplastic vinca alkaloid | rel=r_associated | relid=0 | w=35
  28. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:aromatase inhibitors
    n1=en:cd47 antagonist alx148 | n2=en:aromatase inhibitors | rel=r_associated | relid=0 | w=35
  29. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:azapicyl
    n1=en:cd47 antagonist alx148 | n2=en:azapicyl | rel=r_associated | relid=0 | w=35
  30. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:bromacrylide
    n1=en:cd47 antagonist alx148 | n2=en:bromacrylide | rel=r_associated | relid=0 | w=35
  31. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:ceramide nanoliposome
    n1=en:cd47 antagonist alx148 | n2=en:ceramide nanoliposome | rel=r_associated | relid=0 | w=35
  32. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:chemotherapeutic topical agent
    n1=en:cd47 antagonist alx148 | n2=en:chemotherapeutic topical agent | rel=r_associated | relid=0 | w=35
  33. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:chlorambucil
    n1=en:cd47 antagonist alx148 | n2=en:chlorambucil | rel=r_associated | relid=0 | w=35
  34. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:cinobufagin
    n1=en:cd47 antagonist alx148 | n2=en:cinobufagin | rel=r_associated | relid=0 | w=35
  35. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:ck2-targeting synthetic peptide cigb-300
    n1=en:cd47 antagonist alx148 | n2=en:ck2-targeting synthetic peptide cigb-300 | rel=r_associated | relid=0 | w=35
  36. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:cytostatic agents
    n1=en:cd47 antagonist alx148 | n2=en:cytostatic agents | rel=r_associated | relid=0 | w=35
  37. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:cytotoxic agent
    n1=en:cd47 antagonist alx148 | n2=en:cytotoxic agent | rel=r_associated | relid=0 | w=35
  38. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:dexanabinol
    n1=en:cd47 antagonist alx148 | n2=en:dexanabinol | rel=r_associated | relid=0 | w=35
  39. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:diarylsulfonylurea compound
    n1=en:cd47 antagonist alx148 | n2=en:diarylsulfonylurea compound | rel=r_associated | relid=0 | w=35
  40. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:dihydrolenperone
    n1=en:cd47 antagonist alx148 | n2=en:dihydrolenperone | rel=r_associated | relid=0 | w=35
  41. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:ets-family transcription factor inhibitor tk216
    n1=en:cd47 antagonist alx148 | n2=en:ets-family transcription factor inhibitor tk216 | rel=r_associated | relid=0 | w=35
  42. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:fermented soybean protein beverage
    n1=en:cd47 antagonist alx148 | n2=en:fermented soybean protein beverage | rel=r_associated | relid=0 | w=35
  43. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:folate receptor-targeted vinca alkaloid/mitomycin c ec0225
    n1=en:cd47 antagonist alx148 | n2=en:folate receptor-targeted vinca alkaloid/mitomycin c ec0225 | rel=r_associated | relid=0 | w=35
  44. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:gallium maltolate
    n1=en:cd47 antagonist alx148 | n2=en:gallium maltolate | rel=r_associated | relid=0 | w=35
  45. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:hif-2alpha inhibitor pt2977
    n1=en:cd47 antagonist alx148 | n2=en:hif-2alpha inhibitor pt2977 | rel=r_associated | relid=0 | w=35
  46. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:inproquone
    n1=en:cd47 antagonist alx148 | n2=en:inproquone | rel=r_associated | relid=0 | w=35
  47. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:kanglaite
    n1=en:cd47 antagonist alx148 | n2=en:kanglaite | rel=r_associated | relid=0 | w=35
  48. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:mcl-1 inhibitor mik665
    n1=en:cd47 antagonist alx148 | n2=en:mcl-1 inhibitor mik665 | rel=r_associated | relid=0 | w=35
  49. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:mipsagargin
    n1=en:cd47 antagonist alx148 | n2=en:mipsagargin | rel=r_associated | relid=0 | w=35
  50. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:mutant p53 activator coti-2
    n1=en:cd47 antagonist alx148 | n2=en:mutant p53 activator coti-2 | rel=r_associated | relid=0 | w=35
  51. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:oleandrin
    n1=en:cd47 antagonist alx148 | n2=en:oleandrin | rel=r_associated | relid=0 | w=35
  52. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:oregovomab
    n1=en:cd47 antagonist alx148 | n2=en:oregovomab | rel=r_associated | relid=0 | w=35
  53. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:palbociclib
    n1=en:cd47 antagonist alx148 | n2=en:palbociclib | rel=r_associated | relid=0 | w=35
  54. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:plenaxis
    n1=en:cd47 antagonist alx148 | n2=en:plenaxis | rel=r_associated | relid=0 | w=35
  55. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:rituximab
    n1=en:cd47 antagonist alx148 | n2=en:rituximab | rel=r_associated | relid=0 | w=35
  56. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:splicing inhibitor h3b-8800
    n1=en:cd47 antagonist alx148 | n2=en:splicing inhibitor h3b-8800 | rel=r_associated | relid=0 | w=35
  57. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:synthetic antiestrogen
    n1=en:cd47 antagonist alx148 | n2=en:synthetic antiestrogen | rel=r_associated | relid=0 | w=35
  58. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:tasisulam sodium
    n1=en:cd47 antagonist alx148 | n2=en:tasisulam sodium | rel=r_associated | relid=0 | w=35
  59. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:tolnidamine
    n1=en:cd47 antagonist alx148 | n2=en:tolnidamine | rel=r_associated | relid=0 | w=35
  60. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:topsalysin
    n1=en:cd47 antagonist alx148 | n2=en:topsalysin | rel=r_associated | relid=0 | w=35
  61. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:trpv6 calcium channel inhibitor sor-c13
    n1=en:cd47 antagonist alx148 | n2=en:trpv6 calcium channel inhibitor sor-c13 | rel=r_associated | relid=0 | w=35
  62. en:cd47 antagonist alx148 -- r_associated #0: 35 / 0.814 -> en:vinblastine
    n1=en:cd47 antagonist alx148 | n2=en:vinblastine | rel=r_associated | relid=0 | w=35
  63. en:cd47 antagonist alx148 -- r_associated #0: 34 / 0.791 -> en:androgen antagonists
    n1=en:cd47 antagonist alx148 | n2=en:androgen antagonists | rel=r_associated | relid=0 | w=34
  64. en:cd47 antagonist alx148 -- r_associated #0: 34 / 0.791 -> en:atezolizumab
    n1=en:cd47 antagonist alx148 | n2=en:atezolizumab | rel=r_associated | relid=0 | w=34
  65. en:cd47 antagonist alx148 -- r_associated #0: 34 / 0.791 -> en:azurin:50-77 cell penetrating peptide p28
    n1=en:cd47 antagonist alx148 | n2=en:azurin:50-77 cell penetrating peptide p28 | rel=r_associated | relid=0 | w=34
  66. en:cd47 antagonist alx148 -- r_associated #0: 34 / 0.791 -> en:beta-lapachone prodrug arq 761
    n1=en:cd47 antagonist alx148 | n2=en:beta-lapachone prodrug arq 761 | rel=r_associated | relid=0 | w=34
  67. en:cd47 antagonist alx148 -- r_associated #0: 34 / 0.791 -> en:bromodomain inhibitor abbv-075
    n1=en:cd47 antagonist alx148 | n2=en:bromodomain inhibitor abbv-075 | rel=r_associated | relid=0 | w=34
  68. en:cd47 antagonist alx148 -- r_associated #0: 34 / 0.791 -> en:bxq-350 nanovesicle formulation
    n1=en:cd47 antagonist alx148 | n2=en:bxq-350 nanovesicle formulation | rel=r_associated | relid=0 | w=34
  69. en:cd47 antagonist alx148 -- r_associated #0: 34 / 0.791 -> en:carboxyamidotriazole orotate
    n1=en:cd47 antagonist alx148 | n2=en:carboxyamidotriazole orotate | rel=r_associated | relid=0 | w=34
  70. en:cd47 antagonist alx148 -- r_associated #0: 34 / 0.791 -> en:cladribine
    n1=en:cd47 antagonist alx148 | n2=en:cladribine | rel=r_associated | relid=0 | w=34
  71. en:cd47 antagonist alx148 -- r_associated #0: 34 / 0.791 -> en:e2f1 pathway activator arq 171
    n1=en:cd47 antagonist alx148 | n2=en:e2f1 pathway activator arq 171 | rel=r_associated | relid=0 | w=34
  72. en:cd47 antagonist alx148 -- r_associated #0: 34 / 0.791 -> en:eflornithine
    n1=en:cd47 antagonist alx148 | n2=en:eflornithine | rel=r_associated | relid=0 | w=34
  73. en:cd47 antagonist alx148 -- r_associated #0: 34 / 0.791 -> en:elesclomol sodium
    n1=en:cd47 antagonist alx148 | n2=en:elesclomol sodium | rel=r_associated | relid=0 | w=34
  74. en:cd47 antagonist alx148 -- r_associated #0: 34 / 0.791 -> en:elotuzumab
    n1=en:cd47 antagonist alx148 | n2=en:elotuzumab | rel=r_associated | relid=0 | w=34
  75. en:cd47 antagonist alx148 -- r_associated #0: 34 / 0.791 -> en:enzyme inhibitors
    n1=en:cd47 antagonist alx148 | n2=en:enzyme inhibitors | rel=r_associated | relid=0 | w=34
  76. en:cd47 antagonist alx148 -- r_associated #0: 34 / 0.791 -> en:factor viia inhibitor pci-27483
    n1=en:cd47 antagonist alx148 | n2=en:factor viia inhibitor pci-27483 | rel=r_associated | relid=0 | w=34
  77. en:cd47 antagonist alx148 -- r_associated #0: 34 / 0.791 -> en:hydroxyurea
    n1=en:cd47 antagonist alx148 | n2=en:hydroxyurea | rel=r_associated | relid=0 | w=34
  78. en:cd47 antagonist alx148 -- r_associated #0: 34 / 0.791 -> en:ibritumomab tiuxetan
    n1=en:cd47 antagonist alx148 | n2=en:ibritumomab tiuxetan | rel=r_associated | relid=0 | w=34
  79. en:cd47 antagonist alx148 -- r_associated #0: 34 / 0.791 -> en:liver x receptor beta agonist rgx-104
    n1=en:cd47 antagonist alx148 | n2=en:liver x receptor beta agonist rgx-104 | rel=r_associated | relid=0 | w=34
  80. en:cd47 antagonist alx148 -- r_associated #0: 34 / 0.791 -> en:mechlorethamine
    n1=en:cd47 antagonist alx148 | n2=en:mechlorethamine | rel=r_associated | relid=0 | w=34
  81. en:cd47 antagonist alx148 -- r_associated #0: 34 / 0.791 -> en:ncit antineoplastic agent terminology
    n1=en:cd47 antagonist alx148 | n2=en:ncit antineoplastic agent terminology | rel=r_associated | relid=0 | w=34
  82. en:cd47 antagonist alx148 -- r_associated #0: 34 / 0.791 -> en:p53-hdm2 protein-protein interaction inhibitor apg-115
    n1=en:cd47 antagonist alx148 | n2=en:p53-hdm2 protein-protein interaction inhibitor apg-115 | rel=r_associated | relid=0 | w=34
  83. en:cd47 antagonist alx148 -- r_associated #0: 34 / 0.791 -> en:p53/hdm2 interaction inhibitor cgm097
    n1=en:cd47 antagonist alx148 | n2=en:p53/hdm2 interaction inhibitor cgm097 | rel=r_associated | relid=0 | w=34
  84. en:cd47 antagonist alx148 -- r_associated #0: 34 / 0.791 -> en:pleiotropic pathway modifier cc-122 hydrochloride
    n1=en:cd47 antagonist alx148 | n2=en:pleiotropic pathway modifier cc-122 hydrochloride | rel=r_associated | relid=0 | w=34
  85. en:cd47 antagonist alx148 -- r_associated #0: 34 / 0.791 -> en:poly(adp-ribose) polymerase inhibitors
    n1=en:cd47 antagonist alx148 | n2=en:poly(adp-ribose) polymerase inhibitors | rel=r_associated | relid=0 | w=34
  86. en:cd47 antagonist alx148 -- r_associated #0: 34 / 0.791 -> en:proapoptotic sulindac analog cp-461
    n1=en:cd47 antagonist alx148 | n2=en:proapoptotic sulindac analog cp-461 | rel=r_associated | relid=0 | w=34
  87. en:cd47 antagonist alx148 -- r_associated #0: 34 / 0.791 -> en:proteasome inhibitor
    n1=en:cd47 antagonist alx148 | n2=en:proteasome inhibitor | rel=r_associated | relid=0 | w=34
  88. en:cd47 antagonist alx148 -- r_associated #0: 34 / 0.791 -> en:selective estrogen receptor modulators
    n1=en:cd47 antagonist alx148 | n2=en:selective estrogen receptor modulators | rel=r_associated | relid=0 | w=34
  89. en:cd47 antagonist alx148 -- r_associated #0: 34 / 0.791 -> en:sodium borocaptate
    n1=en:cd47 antagonist alx148 | n2=en:sodium borocaptate | rel=r_associated | relid=0 | w=34
  90. en:cd47 antagonist alx148 -- r_associated #0: 34 / 0.791 -> en:sr-t100 gel
    n1=en:cd47 antagonist alx148 | n2=en:sr-t100 gel | rel=r_associated | relid=0 | w=34
  91. en:cd47 antagonist alx148 -- r_associated #0: 34 / 0.791 -> en:talimogene laherparepvec
    n1=en:cd47 antagonist alx148 | n2=en:talimogene laherparepvec | rel=r_associated | relid=0 | w=34
  92. en:cd47 antagonist alx148 -- r_associated #0: 34 / 0.791 -> en:tazemetostat
    n1=en:cd47 antagonist alx148 | n2=en:tazemetostat | rel=r_associated | relid=0 | w=34
  93. en:cd47 antagonist alx148 -- r_associated #0: 34 / 0.791 -> en:temozolomide
    n1=en:cd47 antagonist alx148 | n2=en:temozolomide | rel=r_associated | relid=0 | w=34
  94. en:cd47 antagonist alx148 -- r_associated #0: 34 / 0.791 -> en:tigapotide
    n1=en:cd47 antagonist alx148 | n2=en:tigapotide | rel=r_associated | relid=0 | w=34
  95. en:cd47 antagonist alx148 -- r_associated #0: 34 / 0.791 -> en:tirapazamine
    n1=en:cd47 antagonist alx148 | n2=en:tirapazamine | rel=r_associated | relid=0 | w=34
  96. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:2-fluorofucose-containing sgn-2ff
    n1=en:cd47 antagonist alx148 | n2=en:2-fluorofucose-containing sgn-2ff | rel=r_associated | relid=0 | w=32
  97. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:antimetabolites
    n1=en:cd47 antagonist alx148 | n2=en:antimetabolites | rel=r_associated | relid=0 | w=32
  98. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:antineoplastic agent combination sm-88
    n1=en:cd47 antagonist alx148 | n2=en:antineoplastic agent combination sm-88 | rel=r_associated | relid=0 | w=32
  99. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:antineoplastic alkaloid
    n1=en:cd47 antagonist alx148 | n2=en:antineoplastic alkaloid | rel=r_associated | relid=0 | w=32
  100. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:antineoplastic metal complex agent
    n1=en:cd47 antagonist alx148 | n2=en:antineoplastic metal complex agent | rel=r_associated | relid=0 | w=32
  101. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:aromatase inhibitors, 3rd generation
    n1=en:cd47 antagonist alx148 | n2=en:aromatase inhibitors, 3rd generation | rel=r_associated | relid=0 | w=32
  102. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:arsenic
    n1=en:cd47 antagonist alx148 | n2=en:arsenic | rel=r_associated | relid=0 | w=32
  103. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:asparaginase
    n1=en:cd47 antagonist alx148 | n2=en:asparaginase | rel=r_associated | relid=0 | w=32
  104. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:belinostat
    n1=en:cd47 antagonist alx148 | n2=en:belinostat | rel=r_associated | relid=0 | w=32
  105. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:blinatumomab
    n1=en:cd47 antagonist alx148 | n2=en:blinatumomab | rel=r_associated | relid=0 | w=32
  106. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:cancell
    n1=en:cd47 antagonist alx148 | n2=en:cancell | rel=r_associated | relid=0 | w=32
  107. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:carbohydrate processing inhibitor
    n1=en:cd47 antagonist alx148 | n2=en:carbohydrate processing inhibitor | rel=r_associated | relid=0 | w=32
  108. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:ceritinib
    n1=en:cd47 antagonist alx148 | n2=en:ceritinib | rel=r_associated | relid=0 | w=32
  109. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:cisplatin
    n1=en:cd47 antagonist alx148 | n2=en:cisplatin | rel=r_associated | relid=0 | w=32
  110. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:clanfenur
    n1=en:cd47 antagonist alx148 | n2=en:clanfenur | rel=r_associated | relid=0 | w=32
  111. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:compound kushen injection
    n1=en:cd47 antagonist alx148 | n2=en:compound kushen injection | rel=r_associated | relid=0 | w=32
  112. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:ctrp terminology
    n1=en:cd47 antagonist alx148 | n2=en:ctrp terminology | rel=r_associated | relid=0 | w=32
  113. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:cycle-phase specific agent
    n1=en:cd47 antagonist alx148 | n2=en:cycle-phase specific agent | rel=r_associated | relid=0 | w=32
  114. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:elesclomol
    n1=en:cd47 antagonist alx148 | n2=en:elesclomol | rel=r_associated | relid=0 | w=32
  115. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:epidermal growth factor receptor tyrosine kinase inhibitor
    n1=en:cd47 antagonist alx148 | n2=en:epidermal growth factor receptor tyrosine kinase inhibitor | rel=r_associated | relid=0 | w=32
  116. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:finasteride
    n1=en:cd47 antagonist alx148 | n2=en:finasteride | rel=r_associated | relid=0 | w=32
  117. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:fludarabine
    n1=en:cd47 antagonist alx148 | n2=en:fludarabine | rel=r_associated | relid=0 | w=32
  118. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:flutamide
    n1=en:cd47 antagonist alx148 | n2=en:flutamide | rel=r_associated | relid=0 | w=32
  119. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:gemcitabine
    n1=en:cd47 antagonist alx148 | n2=en:gemcitabine | rel=r_associated | relid=0 | w=32
  120. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:gemtuzumab ozogamicin
    n1=en:cd47 antagonist alx148 | n2=en:gemtuzumab ozogamicin | rel=r_associated | relid=0 | w=32
  121. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:glucocorticoid receptor antagonist cort125134
    n1=en:cd47 antagonist alx148 | n2=en:glucocorticoid receptor antagonist cort125134 | rel=r_associated | relid=0 | w=32
  122. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:hif-1alpha inhibitor px-478
    n1=en:cd47 antagonist alx148 | n2=en:hif-1alpha inhibitor px-478 | rel=r_associated | relid=0 | w=32
  123. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:huachansu
    n1=en:cd47 antagonist alx148 | n2=en:huachansu | rel=r_associated | relid=0 | w=32
  124. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:intravesical bcg
    n1=en:cd47 antagonist alx148 | n2=en:intravesical bcg | rel=r_associated | relid=0 | w=32
  125. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:ipilimumab
    n1=en:cd47 antagonist alx148 | n2=en:ipilimumab | rel=r_associated | relid=0 | w=32
  126. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:irinotecan
    n1=en:cd47 antagonist alx148 | n2=en:irinotecan | rel=r_associated | relid=0 | w=32
  127. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:melphalan
    n1=en:cd47 antagonist alx148 | n2=en:melphalan | rel=r_associated | relid=0 | w=32
  128. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:napabucasin
    n1=en:cd47 antagonist alx148 | n2=en:napabucasin | rel=r_associated | relid=0 | w=32
  129. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:nilandron
    n1=en:cd47 antagonist alx148 | n2=en:nilandron | rel=r_associated | relid=0 | w=32
  130. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:oblimersen
    n1=en:cd47 antagonist alx148 | n2=en:oblimersen | rel=r_associated | relid=0 | w=32
  131. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:p-cadherin antagonist pf-03732010
    n1=en:cd47 antagonist alx148 | n2=en:p-cadherin antagonist pf-03732010 | rel=r_associated | relid=0 | w=32
  132. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:p-cadherin inhibitor pca062
    n1=en:cd47 antagonist alx148 | n2=en:p-cadherin inhibitor pca062 | rel=r_associated | relid=0 | w=32
  133. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:temsirolimus
    n1=en:cd47 antagonist alx148 | n2=en:temsirolimus | rel=r_associated | relid=0 | w=32
  134. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:thioguanine
    n1=en:cd47 antagonist alx148 | n2=en:thioguanine | rel=r_associated | relid=0 | w=32
  135. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:tyroserleutide
    n1=en:cd47 antagonist alx148 | n2=en:tyroserleutide | rel=r_associated | relid=0 | w=32
  136. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:verteporfin
    n1=en:cd47 antagonist alx148 | n2=en:verteporfin | rel=r_associated | relid=0 | w=32
  137. en:cd47 antagonist alx148 -- r_associated #0: 32 / 0.744 -> en:zinc finger nuclease zfn-603
    n1=en:cd47 antagonist alx148 | n2=en:zinc finger nuclease zfn-603 | rel=r_associated | relid=0 | w=32
  138. en:cd47 antagonist alx148 -- r_associated #0: 31 / 0.721 -> en:alemtuzumab
    n1=en:cd47 antagonist alx148 | n2=en:alemtuzumab | rel=r_associated | relid=0 | w=31
  139. en:cd47 antagonist alx148 -- r_associated #0: 31 / 0.721 -> en:antimetabolites, antineoplastic
    n1=en:cd47 antagonist alx148 | n2=en:antimetabolites, antineoplastic | rel=r_associated | relid=0 | w=31
  140. en:cd47 antagonist alx148 -- r_associated #0: 31 / 0.721 -> en:antineoplastic adjuvants
    n1=en:cd47 antagonist alx148 | n2=en:antineoplastic adjuvants | rel=r_associated | relid=0 | w=31
  141. en:cd47 antagonist alx148 -- r_associated #0: 31 / 0.721 -> en:antineoplastic alkylating agent
    n1=en:cd47 antagonist alx148 | n2=en:antineoplastic alkylating agent | rel=r_associated | relid=0 | w=31
  142. en:cd47 antagonist alx148 -- r_associated #0: 31 / 0.721 -> en:antineoplastic protein inhibitor
    n1=en:cd47 antagonist alx148 | n2=en:antineoplastic protein inhibitor | rel=r_associated | relid=0 | w=31
  143. en:cd47 antagonist alx148 -- r_associated #0: 31 / 0.721 -> en:antineoplastic vaccine
    n1=en:cd47 antagonist alx148 | n2=en:antineoplastic vaccine | rel=r_associated | relid=0 | w=31
  144. en:cd47 antagonist alx148 -- r_associated #0: 31 / 0.721 -> en:apoptotic pathway-targeting antineoplastic agent
    n1=en:cd47 antagonist alx148 | n2=en:apoptotic pathway-targeting antineoplastic agent | rel=r_associated | relid=0 | w=31
  145. en:cd47 antagonist alx148 -- r_associated #0: 31 / 0.721 -> en:birinapant
    n1=en:cd47 antagonist alx148 | n2=en:birinapant | rel=r_associated | relid=0 | w=31
  146. en:cd47 antagonist alx148 -- r_associated #0: 31 / 0.721 -> en:catumaxomab
    n1=en:cd47 antagonist alx148 | n2=en:catumaxomab | rel=r_associated | relid=0 | w=31
  147. en:cd47 antagonist alx148 -- r_associated #0: 31 / 0.721 -> en:cisplatin/vinblastine/cell penetration enhancer formulation int230-6
    n1=en:cd47 antagonist alx148 | n2=en:cisplatin/vinblastine/cell penetration enhancer formulation int230-6 | rel=r_associated | relid=0 | w=31
  148. en:cd47 antagonist alx148 -- r_associated #0: 31 / 0.721 -> en:dimethyl sulfoxide
    n1=en:cd47 antagonist alx148 | n2=en:dimethyl sulfoxide | rel=r_associated | relid=0 | w=31
  149. en:cd47 antagonist alx148 -- r_associated #0: 31 / 0.721 -> en:enteric-coated trpm8 agonist d-3263 hydrochloride
    n1=en:cd47 antagonist alx148 | n2=en:enteric-coated trpm8 agonist d-3263 hydrochloride | rel=r_associated | relid=0 | w=31
  150. en:cd47 antagonist alx148 -- r_associated #0: 31 / 0.721 -> en:epothilones
    n1=en:cd47 antagonist alx148 | n2=en:epothilones | rel=r_associated | relid=0 | w=31
  151. en:cd47 antagonist alx148 -- r_associated #0: 31 / 0.721 -> en:fenretinide
    n1=en:cd47 antagonist alx148 | n2=en:fenretinide | rel=r_associated | relid=0 | w=31
  152. en:cd47 antagonist alx148 -- r_associated #0: 31 / 0.721 -> en:gallium nitrate
    n1=en:cd47 antagonist alx148 | n2=en:gallium nitrate | rel=r_associated | relid=0 | w=31
  153. en:cd47 antagonist alx148 -- r_associated #0: 31 / 0.721 -> en:giracodazole
    n1=en:cd47 antagonist alx148 | n2=en:giracodazole | rel=r_associated | relid=0 | w=31
  154. en:cd47 antagonist alx148 -- r_associated #0: 31 / 0.721 -> en:huaier extract granule
    n1=en:cd47 antagonist alx148 | n2=en:huaier extract granule | rel=r_associated | relid=0 | w=31
  155. en:cd47 antagonist alx148 -- r_associated #0: 31 / 0.721 -> en:ibritumomab
    n1=en:cd47 antagonist alx148 | n2=en:ibritumomab | rel=r_associated | relid=0 | w=31
  156. en:cd47 antagonist alx148 -- r_associated #0: 31 / 0.721 -> en:idelalisib
    n1=en:cd47 antagonist alx148 | n2=en:idelalisib | rel=r_associated | relid=0 | w=31
  157. en:cd47 antagonist alx148 -- r_associated #0: 31 / 0.721 -> en:ingenol mebutate gel
    n1=en:cd47 antagonist alx148 | n2=en:ingenol mebutate gel | rel=r_associated | relid=0 | w=31
  158. en:cd47 antagonist alx148 -- r_associated #0: 31 / 0.721 -> en:lenalidomide
    n1=en:cd47 antagonist alx148 | n2=en:lenalidomide | rel=r_associated | relid=0 | w=31
  159. en:cd47 antagonist alx148 -- r_associated #0: 31 / 0.721 -> en:miltefosine
    n1=en:cd47 antagonist alx148 | n2=en:miltefosine | rel=r_associated | relid=0 | w=31
  160. en:cd47 antagonist alx148 -- r_associated #0: 31 / 0.721 -> en:nintedanib
    n1=en:cd47 antagonist alx148 | n2=en:nintedanib | rel=r_associated | relid=0 | w=31
  161. en:cd47 antagonist alx148 -- r_associated #0: 31 / 0.721 -> en:polyamine analogue
    n1=en:cd47 antagonist alx148 | n2=en:polyamine analogue | rel=r_associated | relid=0 | w=31
  162. en:cd47 antagonist alx148 -- r_associated #0: 31 / 0.721 -> en:prima-1 analog apr-246
    n1=en:cd47 antagonist alx148 | n2=en:prima-1 analog apr-246 | rel=r_associated | relid=0 | w=31
  163. en:cd47 antagonist alx148 -- r_associated #0: 31 / 0.721 -> en:procarbazine
    n1=en:cd47 antagonist alx148 | n2=en:procarbazine | rel=r_associated | relid=0 | w=31
  164. en:cd47 antagonist alx148 -- r_associated #0: 31 / 0.721 -> en:pyridyl cyanoguanidine chs 828
    n1=en:cd47 antagonist alx148 | n2=en:pyridyl cyanoguanidine chs 828 | rel=r_associated | relid=0 | w=31
  165. en:cd47 antagonist alx148 -- r_associated #0: 31 / 0.721 -> en:ruxolitinib
    n1=en:cd47 antagonist alx148 | n2=en:ruxolitinib | rel=r_associated | relid=0 | w=31
  166. en:cd47 antagonist alx148 -- r_associated #0: 31 / 0.721 -> en:signal transduction inhibitor
    n1=en:cd47 antagonist alx148 | n2=en:signal transduction inhibitor | rel=r_associated | relid=0 | w=31
  167. en:cd47 antagonist alx148 -- r_associated #0: 31 / 0.721 -> en:teglarinad
    n1=en:cd47 antagonist alx148 | n2=en:teglarinad | rel=r_associated | relid=0 | w=31
  168. en:cd47 antagonist alx148 -- r_associated #0: 31 / 0.721 -> en:terfluranol
    n1=en:cd47 antagonist alx148 | n2=en:terfluranol | rel=r_associated | relid=0 | w=31
  169. en:cd47 antagonist alx148 -- r_associated #0: 31 / 0.721 -> en:testolactone
    n1=en:cd47 antagonist alx148 | n2=en:testolactone | rel=r_associated | relid=0 | w=31
  170. en:cd47 antagonist alx148 -- r_associated #0: 31 / 0.721 -> en:trimetrexate
    n1=en:cd47 antagonist alx148 | n2=en:trimetrexate | rel=r_associated | relid=0 | w=31
  171. en:cd47 antagonist alx148 -- r_associated #0: 31 / 0.721 -> en:vincristine
    n1=en:cd47 antagonist alx148 | n2=en:vincristine | rel=r_associated | relid=0 | w=31
  172. en:cd47 antagonist alx148 -- r_associated #0: 31 / 0.721 -> en:xanthohumol
    n1=en:cd47 antagonist alx148 | n2=en:xanthohumol | rel=r_associated | relid=0 | w=31
  173. en:cd47 antagonist alx148 -- r_associated #0: 31 / 0.721 -> en:zinc finger nuclease zfn-758
    n1=en:cd47 antagonist alx148 | n2=en:zinc finger nuclease zfn-758 | rel=r_associated | relid=0 | w=31
  174. en:cd47 antagonist alx148 -- r_associated #0: 30 / 0.698 -> en:ad5-cmv-nis
    n1=en:cd47 antagonist alx148 | n2=en:ad5-cmv-nis | rel=r_associated | relid=0 | w=30
  175. en:cd47 antagonist alx148 -- r_associated #0: 30 / 0.698 -> en:alvocidib hydrochloride
    n1=en:cd47 antagonist alx148 | n2=en:alvocidib hydrochloride | rel=r_associated | relid=0 | w=30
  176. en:cd47 antagonist alx148 -- r_associated #0: 30 / 0.698 -> en:amsacrine
    n1=en:cd47 antagonist alx148 | n2=en:amsacrine | rel=r_associated | relid=0 | w=30
  177. en:cd47 antagonist alx148 -- r_associated #0: 30 / 0.698 -> en:antileukemic agent
    n1=en:cd47 antagonist alx148 | n2=en:antileukemic agent | rel=r_associated | relid=0 | w=30
  178. en:cd47 antagonist alx148 -- r_associated #0: 30 / 0.698 -> en:antineoplastic metal complex preparation
    n1=en:cd47 antagonist alx148 | n2=en:antineoplastic metal complex preparation | rel=r_associated | relid=0 | w=30
  179. en:cd47 antagonist alx148 -- r_associated #0: 30 / 0.698 -> en:artemether sublingual spray
    n1=en:cd47 antagonist alx148 | n2=en:artemether sublingual spray | rel=r_associated | relid=0 | w=30
  180. en:cd47 antagonist alx148 -- r_associated #0: 30 / 0.698 -> en:bicalutamide
    n1=en:cd47 antagonist alx148 | n2=en:bicalutamide | rel=r_associated | relid=0 | w=30
  181. en:cd47 antagonist alx148 -- r_associated #0: 30 / 0.698 -> en:breflate
    n1=en:cd47 antagonist alx148 | n2=en:breflate | rel=r_associated | relid=0 | w=30
  182. en:cd47 antagonist alx148 -- r_associated #0: 30 / 0.698 -> en:budotitane
    n1=en:cd47 antagonist alx148 | n2=en:budotitane | rel=r_associated | relid=0 | w=30
  183. en:cd47 antagonist alx148 -- r_associated #0: 30 / 0.698 -> en:darinaparsin
    n1=en:cd47 antagonist alx148 | n2=en:darinaparsin | rel=r_associated | relid=0 | w=30
  184. en:cd47 antagonist alx148 -- r_associated #0: 30 / 0.698 -> en:estrogen antagonists
    n1=en:cd47 antagonist alx148 | n2=en:estrogen antagonists | rel=r_associated | relid=0 | w=30
  185. en:cd47 antagonist alx148 -- r_associated #0: 30 / 0.698 -> en:etoposide
    n1=en:cd47 antagonist alx148 | n2=en:etoposide | rel=r_associated | relid=0 | w=30
  186. en:cd47 antagonist alx148 -- r_associated #0: 30 / 0.698 -> en:fluorouracil
    n1=en:cd47 antagonist alx148 | n2=en:fluorouracil | rel=r_associated | relid=0 | w=30
  187. en:cd47 antagonist alx148 -- r_associated #0: 30 / 0.698 -> en:forodesine
    n1=en:cd47 antagonist alx148 | n2=en:forodesine | rel=r_associated | relid=0 | w=30
  188. en:cd47 antagonist alx148 -- r_associated #0: 30 / 0.698 -> en:fosquidone
    n1=en:cd47 antagonist alx148 | n2=en:fosquidone | rel=r_associated | relid=0 | w=30
  189. en:cd47 antagonist alx148 -- r_associated #0: 30 / 0.698 -> en:idasanutlin
    n1=en:cd47 antagonist alx148 | n2=en:idasanutlin | rel=r_associated | relid=0 | w=30
  190. en:cd47 antagonist alx148 -- r_associated #0: 30 / 0.698 -> en:intiquinatine
    n1=en:cd47 antagonist alx148 | n2=en:intiquinatine | rel=r_associated | relid=0 | w=30
  191. en:cd47 antagonist alx148 -- r_associated #0: 30 / 0.698 -> en:mitoquidone
    n1=en:cd47 antagonist alx148 | n2=en:mitoquidone | rel=r_associated | relid=0 | w=30
  192. en:cd47 antagonist alx148 -- r_associated #0: 30 / 0.698 -> en:mouse renal adenocarcinoma cell-encapsulated agarose-agarose macrobeads
    n1=en:cd47 antagonist alx148 | n2=en:mouse renal adenocarcinoma cell-encapsulated agarose-agarose macrobeads | rel=r_associated | relid=0 | w=30
  193. en:cd47 antagonist alx148 -- r_associated #0: 30 / 0.698 -> en:obatoclax
    n1=en:cd47 antagonist alx148 | n2=en:obatoclax | rel=r_associated | relid=0 | w=30
  194. en:cd47 antagonist alx148 -- r_associated #0: 30 / 0.698 -> en:pegylated recombinant l-asparaginase erwinia chrysanthemi
    n1=en:cd47 antagonist alx148 | n2=en:pegylated recombinant l-asparaginase erwinia chrysanthemi | rel=r_associated | relid=0 | w=30
  195. en:cd47 antagonist alx148 -- r_associated #0: 30 / 0.698 -> en:pomalidomide
    n1=en:cd47 antagonist alx148 | n2=en:pomalidomide | rel=r_associated | relid=0 | w=30
  196. en:cd47 antagonist alx148 -- r_associated #0: 30 / 0.698 -> en:pr-104
    n1=en:cd47 antagonist alx148 | n2=en:pr-104 | rel=r_associated | relid=0 | w=30
  197. en:cd47 antagonist alx148 -- r_associated #0: 30 / 0.698 -> en:razoxane
    n1=en:cd47 antagonist alx148 | n2=en:razoxane | rel=r_associated | relid=0 | w=30
  198. en:cd47 antagonist alx148 -- r_associated #0: 30 / 0.698 -> en:synthesis inhibitors, dna
    n1=en:cd47 antagonist alx148 | n2=en:synthesis inhibitors, dna | rel=r_associated | relid=0 | w=30
  199. en:cd47 antagonist alx148 -- r_associated #0: 30 / 0.698 -> en:topical betulinic acid
    n1=en:cd47 antagonist alx148 | n2=en:topical betulinic acid | rel=r_associated | relid=0 | w=30
  200. en:cd47 antagonist alx148 -- r_associated #0: 30 / 0.698 -> en:tositumomab
    n1=en:cd47 antagonist alx148 | n2=en:tositumomab | rel=r_associated | relid=0 | w=30
  201. en:cd47 antagonist alx148 -- r_associated #0: 30 / 0.698 -> en:trastuzumab
    n1=en:cd47 antagonist alx148 | n2=en:trastuzumab | rel=r_associated | relid=0 | w=30
  202. en:cd47 antagonist alx148 -- r_associated #0: 30 / 0.698 -> en:tretazicar
    n1=en:cd47 antagonist alx148 | n2=en:tretazicar | rel=r_associated | relid=0 | w=30
  203. en:cd47 antagonist alx148 -- r_associated #0: 30 / 0.698 -> en:urethane
    n1=en:cd47 antagonist alx148 | n2=en:urethane | rel=r_associated | relid=0 | w=30
  204. en:cd47 antagonist alx148 -- r_associated #0: 29 / 0.674 -> en:ambazone
    n1=en:cd47 antagonist alx148 | n2=en:ambazone | rel=r_associated | relid=0 | w=29
  205. en:cd47 antagonist alx148 -- r_associated #0: 29 / 0.674 -> en:anticarcinogenic agents
    n1=en:cd47 antagonist alx148 | n2=en:anticarcinogenic agents | rel=r_associated | relid=0 | w=29
  206. en:cd47 antagonist alx148 -- r_associated #0: 29 / 0.674 -> en:antimitotic agents
    n1=en:cd47 antagonist alx148 | n2=en:antimitotic agents | rel=r_associated | relid=0 | w=29
  207. en:cd47 antagonist alx148 -- r_associated #0: 29 / 0.674 -> en:cannabidiol
    n1=en:cd47 antagonist alx148 | n2=en:cannabidiol | rel=r_associated | relid=0 | w=29
  208. en:cd47 antagonist alx148 -- r_associated #0: 29 / 0.674 -> en:cd5789 cream
    n1=en:cd47 antagonist alx148 | n2=en:cd5789 cream | rel=r_associated | relid=0 | w=29
  209. en:cd47 antagonist alx148 -- r_associated #0: 29 / 0.674 -> en:ctrp agent terminology
    n1=en:cd47 antagonist alx148 | n2=en:ctrp agent terminology | rel=r_associated | relid=0 | w=29
  210. en:cd47 antagonist alx148 -- r_associated #0: 29 / 0.674 -> en:cycle-phase nonspecific agent
    n1=en:cd47 antagonist alx148 | n2=en:cycle-phase nonspecific agent | rel=r_associated | relid=0 | w=29
  211. en:cd47 antagonist alx148 -- r_associated #0: 29 / 0.674 -> en:dacarbazine
    n1=en:cd47 antagonist alx148 | n2=en:dacarbazine | rel=r_associated | relid=0 | w=29
  212. en:cd47 antagonist alx148 -- r_associated #0: 29 / 0.674 -> en:erastin analogue prlx 93936
    n1=en:cd47 antagonist alx148 | n2=en:erastin analogue prlx 93936 | rel=r_associated | relid=0 | w=29
  213. en:cd47 antagonist alx148 -- r_associated #0: 29 / 0.674 -> en:fazarabine
    n1=en:cd47 antagonist alx148 | n2=en:fazarabine | rel=r_associated | relid=0 | w=29
  214. en:cd47 antagonist alx148 -- r_associated #0: 29 / 0.674 -> en:floxuridine
    n1=en:cd47 antagonist alx148 | n2=en:floxuridine | rel=r_associated | relid=0 | w=29
  215. en:cd47 antagonist alx148 -- r_associated #0: 29 / 0.674 -> en:hafnium oxide-containing nanoparticles nbtxr3
    n1=en:cd47 antagonist alx148 | n2=en:hafnium oxide-containing nanoparticles nbtxr3 | rel=r_associated | relid=0 | w=29
  216. en:cd47 antagonist alx148 -- r_associated #0: 29 / 0.674 -> en:heat shock protein inhibitor
    n1=en:cd47 antagonist alx148 | n2=en:heat shock protein inhibitor | rel=r_associated | relid=0 | w=29
  217. en:cd47 antagonist alx148 -- r_associated #0: 29 / 0.674 -> en:ingenol mebutate
    n1=en:cd47 antagonist alx148 | n2=en:ingenol mebutate | rel=r_associated | relid=0 | w=29
  218. en:cd47 antagonist alx148 -- r_associated #0: 29 / 0.674 -> en:jin fu kang
    n1=en:cd47 antagonist alx148 | n2=en:jin fu kang | rel=r_associated | relid=0 | w=29
  219. en:cd47 antagonist alx148 -- r_associated #0: 29 / 0.674 -> en:lactoferrin-derived lytic peptide ltx-315
    n1=en:cd47 antagonist alx148 | n2=en:lactoferrin-derived lytic peptide ltx-315 | rel=r_associated | relid=0 | w=29
  220. en:cd47 antagonist alx148 -- r_associated #0: 29 / 0.674 -> en:metaiodobenzylguanidine[131i]
    n1=en:cd47 antagonist alx148 | n2=en:metaiodobenzylguanidine[131i] | rel=r_associated | relid=0 | w=29
  221. en:cd47 antagonist alx148 -- r_associated #0: 29 / 0.674 -> en:methotrexate
    n1=en:cd47 antagonist alx148 | n2=en:methotrexate | rel=r_associated | relid=0 | w=29
  222. en:cd47 antagonist alx148 -- r_associated #0: 29 / 0.674 -> en:molecular target inhibitors
    n1=en:cd47 antagonist alx148 | n2=en:molecular target inhibitors | rel=r_associated | relid=0 | w=29
  223. en:cd47 antagonist alx148 -- r_associated #0: 29 / 0.674 -> en:myeloablative agonist
    n1=en:cd47 antagonist alx148 | n2=en:myeloablative agonist | rel=r_associated | relid=0 | w=29
  224. en:cd47 antagonist alx148 -- r_associated #0: 29 / 0.674 -> en:naptumomab
    n1=en:cd47 antagonist alx148 | n2=en:naptumomab | rel=r_associated | relid=0 | w=29
  225. en:cd47 antagonist alx148 -- r_associated #0: 29 / 0.674 -> en:olaparib
    n1=en:cd47 antagonist alx148 | n2=en:olaparib | rel=r_associated | relid=0 | w=29
  226. en:cd47 antagonist alx148 -- r_associated #0: 29 / 0.674 -> en:pertuzumab
    n1=en:cd47 antagonist alx148 | n2=en:pertuzumab | rel=r_associated | relid=0 | w=29
  227. en:cd47 antagonist alx148 -- r_associated #0: 29 / 0.674 -> en:plevitrexed
    n1=en:cd47 antagonist alx148 | n2=en:plevitrexed | rel=r_associated | relid=0 | w=29
  228. en:cd47 antagonist alx148 -- r_associated #0: 29 / 0.674 -> en:ramucirumab
    n1=en:cd47 antagonist alx148 | n2=en:ramucirumab | rel=r_associated | relid=0 | w=29
  229. en:cd47 antagonist alx148 -- r_associated #0: 29 / 0.674 -> en:recombinant ephb4-hsa fusion protein
    n1=en:cd47 antagonist alx148 | n2=en:recombinant ephb4-hsa fusion protein | rel=r_associated | relid=0 | w=29
  230. en:cd47 antagonist alx148 -- r_associated #0: 29 / 0.674 -> en:selinexor
    n1=en:cd47 antagonist alx148 | n2=en:selinexor | rel=r_associated | relid=0 | w=29
  231. en:cd47 antagonist alx148 -- r_associated #0: 29 / 0.674 -> en:streptozocin
    n1=en:cd47 antagonist alx148 | n2=en:streptozocin | rel=r_associated | relid=0 | w=29
  232. en:cd47 antagonist alx148 -- r_associated #0: 29 / 0.674 -> en:triptorelin
    n1=en:cd47 antagonist alx148 | n2=en:triptorelin | rel=r_associated | relid=0 | w=29
  233. en:cd47 antagonist alx148 -- r_associated #0: 28 / 0.651 -> en:alkylating agents
    n1=en:cd47 antagonist alx148 | n2=en:alkylating agents | rel=r_associated | relid=0 | w=28
  234. en:cd47 antagonist alx148 -- r_associated #0: 28 / 0.651 -> en:aminopterin
    n1=en:cd47 antagonist alx148 | n2=en:aminopterin | rel=r_associated | relid=0 | w=28
  235. en:cd47 antagonist alx148 -- r_associated #0: 28 / 0.651 -> en:antineoplastic agents, phytogenic
    n1=en:cd47 antagonist alx148 | n2=en:antineoplastic agents, phytogenic | rel=r_associated | relid=0 | w=28
  236. en:cd47 antagonist alx148 -- r_associated #0: 28 / 0.651 -> en:antineoplastic anthraquinone
    n1=en:cd47 antagonist alx148 | n2=en:antineoplastic anthraquinone | rel=r_associated | relid=0 | w=28
  237. en:cd47 antagonist alx148 -- r_associated #0: 28 / 0.651 -> en:antineoplastic hormones
    n1=en:cd47 antagonist alx148 | n2=en:antineoplastic hormones | rel=r_associated | relid=0 | w=28
  238. en:cd47 antagonist alx148 -- r_associated #0: 28 / 0.651 -> en:asp4132
    n1=en:cd47 antagonist alx148 | n2=en:asp4132 | rel=r_associated | relid=0 | w=28
  239. en:cd47 antagonist alx148 -- r_associated #0: 28 / 0.651 -> en:atr-101
    n1=en:cd47 antagonist alx148 | n2=en:atr-101 | rel=r_associated | relid=0 | w=28
  240. en:cd47 antagonist alx148 -- r_associated #0: 28 / 0.651 -> en:brentuximab vedotin
    n1=en:cd47 antagonist alx148 | n2=en:brentuximab vedotin | rel=r_associated | relid=0 | w=28
  241. en:cd47 antagonist alx148 -- r_associated #0: 28 / 0.651 -> en:cabozantinib
    n1=en:cd47 antagonist alx148 | n2=en:cabozantinib | rel=r_associated | relid=0 | w=28
  242. en:cd47 antagonist alx148 -- r_associated #0: 28 / 0.651 -> en:caricotamide/tretazicar
    n1=en:cd47 antagonist alx148 | n2=en:caricotamide/tretazicar | rel=r_associated | relid=0 | w=28
  243. en:cd47 antagonist alx148 -- r_associated #0: 28 / 0.651 -> en:carmustine
    n1=en:cd47 antagonist alx148 | n2=en:carmustine | rel=r_associated | relid=0 | w=28
  244. en:cd47 antagonist alx148 -- r_associated #0: 28 / 0.651 -> en:cephalostatin
    n1=en:cd47 antagonist alx148 | n2=en:cephalostatin | rel=r_associated | relid=0 | w=28
  245. en:cd47 antagonist alx148 -- r_associated #0: 28 / 0.651 -> en:demethylating agent
    n1=en:cd47 antagonist alx148 | n2=en:demethylating agent | rel=r_associated | relid=0 | w=28
  246. en:cd47 antagonist alx148 -- r_associated #0: 28 / 0.651 -> en:diethylstilbestrol
    n1=en:cd47 antagonist alx148 | n2=en:diethylstilbestrol | rel=r_associated | relid=0 | w=28
  247. en:cd47 antagonist alx148 -- r_associated #0: 28 / 0.651 -> en:dna-rna transcription regulator
    n1=en:cd47 antagonist alx148 | n2=en:dna-rna transcription regulator | rel=r_associated | relid=0 | w=28
  248. en:cd47 antagonist alx148 -- r_associated #0: 28 / 0.651 -> en:everolimus
    n1=en:cd47 antagonist alx148 | n2=en:everolimus | rel=r_associated | relid=0 | w=28
  249. en:cd47 antagonist alx148 -- r_associated #0: 28 / 0.651 -> en:harringtonines
    n1=en:cd47 antagonist alx148 | n2=en:harringtonines | rel=r_associated | relid=0 | w=28
  250. en:cd47 antagonist alx148 -- r_associated #0: 28 / 0.651 -> en:heparan sulfate glycosaminoglycan mimetic m402
    n1=en:cd47 antagonist alx148 | n2=en:heparan sulfate glycosaminoglycan mimetic m402 | rel=r_associated | relid=0 | w=28
  251. en:cd47 antagonist alx148 -- r_associated #0: 28 / 0.651 -> en:hypoxia-activated prodrug th-302
    n1=en:cd47 antagonist alx148 | n2=en:hypoxia-activated prodrug th-302 | rel=r_associated | relid=0 | w=28
  252. en:cd47 antagonist alx148 -- r_associated #0: 28 / 0.651 -> en:lipid encapsulated anti-plk1 sirna tkm-plk1
    n1=en:cd47 antagonist alx148 | n2=en:lipid encapsulated anti-plk1 sirna tkm-plk1 | rel=r_associated | relid=0 | w=28
  253. en:cd47 antagonist alx148 -- r_associated #0: 28 / 0.651 -> en:lysine-specific demethylase 1 inhibitor incb059872
    n1=en:cd47 antagonist alx148 | n2=en:lysine-specific demethylase 1 inhibitor incb059872 | rel=r_associated | relid=0 | w=28
  254. en:cd47 antagonist alx148 -- r_associated #0: 28 / 0.651 -> en:mcl-1 inhibitor amg 176
    n1=en:cd47 antagonist alx148 | n2=en:mcl-1 inhibitor amg 176 | rel=r_associated | relid=0 | w=28
  255. en:cd47 antagonist alx148 -- r_associated #0: 28 / 0.651 -> en:modified vitamin d binding protein macrophage activator ef-022
    n1=en:cd47 antagonist alx148 | n2=en:modified vitamin d binding protein macrophage activator ef-022 | rel=r_associated | relid=0 | w=28
  256. en:cd47 antagonist alx148 -- r_associated #0: 28 / 0.651 -> en:morinda citrifolia extract
    n1=en:cd47 antagonist alx148 | n2=en:morinda citrifolia extract | rel=r_associated | relid=0 | w=28
  257. en:cd47 antagonist alx148 -- r_associated #0: 28 / 0.651 -> en:p-cadherin-targeting agent pf-06671008
    n1=en:cd47 antagonist alx148 | n2=en:p-cadherin-targeting agent pf-06671008 | rel=r_associated | relid=0 | w=28
  258. en:cd47 antagonist alx148 -- r_associated #0: 28 / 0.651 -> en:p53-hdm2 interaction inhibitor mi-773
    n1=en:cd47 antagonist alx148 | n2=en:p53-hdm2 interaction inhibitor mi-773 | rel=r_associated | relid=0 | w=28
  259. en:cd47 antagonist alx148 -- r_associated #0: 28 / 0.651 -> en:pegylated human recombinant arginase 1 aeb1102
    n1=en:cd47 antagonist alx148 | n2=en:pegylated human recombinant arginase 1 aeb1102 | rel=r_associated | relid=0 | w=28
  260. en:cd47 antagonist alx148 -- r_associated #0: 28 / 0.651 -> en:pembrolizumab
    n1=en:cd47 antagonist alx148 | n2=en:pembrolizumab | rel=r_associated | relid=0 | w=28
  261. en:cd47 antagonist alx148 -- r_associated #0: 28 / 0.651 -> en:photosensitizing agent
    n1=en:cd47 antagonist alx148 | n2=en:photosensitizing agent | rel=r_associated | relid=0 | w=28
  262. en:cd47 antagonist alx148 -- r_associated #0: 28 / 0.651 -> en:procaspase activating compound-1 vo-100
    n1=en:cd47 antagonist alx148 | n2=en:procaspase activating compound-1 vo-100 | rel=r_associated | relid=0 | w=28
  263. en:cd47 antagonist alx148 -- r_associated #0: 28 / 0.651 -> en:samarium sm 153 lexidronam
    n1=en:cd47 antagonist alx148 | n2=en:samarium sm 153 lexidronam | rel=r_associated | relid=0 | w=28
  264. en:cd47 antagonist alx148 -- r_associated #0: 28 / 0.651 -> en:sodium dichloroacetate
    n1=en:cd47 antagonist alx148 | n2=en:sodium dichloroacetate | rel=r_associated | relid=0 | w=28
  265. en:cd47 antagonist alx148 -- r_associated #0: 28 / 0.651 -> en:taurultam
    n1=en:cd47 antagonist alx148 | n2=en:taurultam | rel=r_associated | relid=0 | w=28
  266. en:cd47 antagonist alx148 -- r_associated #0: 28 / 0.651 -> en:teglarinad chloride
    n1=en:cd47 antagonist alx148 | n2=en:teglarinad chloride | rel=r_associated | relid=0 | w=28
  267. en:cd47 antagonist alx148 -- r_associated #0: 28 / 0.651 -> en:thioureidobutyronitrile
    n1=en:cd47 antagonist alx148 | n2=en:thioureidobutyronitrile | rel=r_associated | relid=0 | w=28
  268. en:cd47 antagonist alx148 -- r_associated #0: 28 / 0.651 -> en:tilorone
    n1=en:cd47 antagonist alx148 | n2=en:tilorone | rel=r_associated | relid=0 | w=28
  269. en:cd47 antagonist alx148 -- r_associated #0: 28 / 0.651 -> en:venetoclax
    n1=en:cd47 antagonist alx148 | n2=en:venetoclax | rel=r_associated | relid=0 | w=28
  270. en:cd47 antagonist alx148 -- r_associated #0: 28 / 0.651 -> en:vinca alkaloids
    n1=en:cd47 antagonist alx148 | n2=en:vinca alkaloids | rel=r_associated | relid=0 | w=28
  271. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:2-hydroxyoleic acid
    n1=en:cd47 antagonist alx148 | n2=en:2-hydroxyoleic acid | rel=r_associated | relid=0 | w=27
  272. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:adenosine a3 receptor agonist cf102
    n1=en:cd47 antagonist alx148 | n2=en:adenosine a3 receptor agonist cf102 | rel=r_associated | relid=0 | w=27
  273. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:amidino tic
    n1=en:cd47 antagonist alx148 | n2=en:amidino tic | rel=r_associated | relid=0 | w=27
  274. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:aminolevulinic acid
    n1=en:cd47 antagonist alx148 | n2=en:aminolevulinic acid | rel=r_associated | relid=0 | w=27
  275. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:antimetastatic agent
    n1=en:cd47 antagonist alx148 | n2=en:antimetastatic agent | rel=r_associated | relid=0 | w=27
  276. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:antineoplastic antibiotic
    n1=en:cd47 antagonist alx148 | n2=en:antineoplastic antibiotic | rel=r_associated | relid=0 | w=27
  277. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:antineoplastic biological agent
    n1=en:cd47 antagonist alx148 | n2=en:antineoplastic biological agent | rel=r_associated | relid=0 | w=27
  278. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:antineoplastics, other
    n1=en:cd47 antagonist alx148 | n2=en:antineoplastics, other | rel=r_associated | relid=0 | w=27
  279. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:asp9853
    n1=en:cd47 antagonist alx148 | n2=en:asp9853 | rel=r_associated | relid=0 | w=27
  280. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:azacitidine
    n1=en:cd47 antagonist alx148 | n2=en:azacitidine | rel=r_associated | relid=0 | w=27
  281. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:benaxibine
    n1=en:cd47 antagonist alx148 | n2=en:benaxibine | rel=r_associated | relid=0 | w=27
  282. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:biological response modifiers
    n1=en:cd47 antagonist alx148 | n2=en:biological response modifiers | rel=r_associated | relid=0 | w=27
  283. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:busulfan
    n1=en:cd47 antagonist alx148 | n2=en:busulfan | rel=r_associated | relid=0 | w=27
  284. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:cell differentiating agent
    n1=en:cd47 antagonist alx148 | n2=en:cell differentiating agent | rel=r_associated | relid=0 | w=27
  285. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:cytoprotective agent
    n1=en:cd47 antagonist alx148 | n2=en:cytoprotective agent | rel=r_associated | relid=0 | w=27
  286. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:e-selectin antagonist gmi-1271
    n1=en:cd47 antagonist alx148 | n2=en:e-selectin antagonist gmi-1271 | rel=r_associated | relid=0 | w=27
  287. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:enzalutamide
    n1=en:cd47 antagonist alx148 | n2=en:enzalutamide | rel=r_associated | relid=0 | w=27
  288. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:erythrocyte-encapsulated l-asparaginase suspension
    n1=en:cd47 antagonist alx148 | n2=en:erythrocyte-encapsulated l-asparaginase suspension | rel=r_associated | relid=0 | w=27
  289. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:fact complex-targeting curaxin cbl0137
    n1=en:cd47 antagonist alx148 | n2=en:fact complex-targeting curaxin cbl0137 | rel=r_associated | relid=0 | w=27
  290. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:galectin inhibitor gr-md-02
    n1=en:cd47 antagonist alx148 | n2=en:galectin inhibitor gr-md-02 | rel=r_associated | relid=0 | w=27
  291. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:imiquimod
    n1=en:cd47 antagonist alx148 | n2=en:imiquimod | rel=r_associated | relid=0 | w=27
  292. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:lapachone
    n1=en:cd47 antagonist alx148 | n2=en:lapachone | rel=r_associated | relid=0 | w=27
  293. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:liposome-encapsulated mir-34 mimic mrx34
    n1=en:cd47 antagonist alx148 | n2=en:liposome-encapsulated mir-34 mimic mrx34 | rel=r_associated | relid=0 | w=27
  294. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:methoxyamine
    n1=en:cd47 antagonist alx148 | n2=en:methoxyamine | rel=r_associated | relid=0 | w=27
  295. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:monocarboxylate transporter 1 inhibitor azd3965
    n1=en:cd47 antagonist alx148 | n2=en:monocarboxylate transporter 1 inhibitor azd3965 | rel=r_associated | relid=0 | w=27
  296. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:paclitaxel
    n1=en:cd47 antagonist alx148 | n2=en:paclitaxel | rel=r_associated | relid=0 | w=27
  297. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:polyamine synthesis inhibitor
    n1=en:cd47 antagonist alx148 | n2=en:polyamine synthesis inhibitor | rel=r_associated | relid=0 | w=27
  298. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:protective agents
    n1=en:cd47 antagonist alx148 | n2=en:protective agents | rel=r_associated | relid=0 | w=27
  299. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:quarfloxin
    n1=en:cd47 antagonist alx148 | n2=en:quarfloxin | rel=r_associated | relid=0 | w=27
  300. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:radiosensitizing agent
    n1=en:cd47 antagonist alx148 | n2=en:radiosensitizing agent | rel=r_associated | relid=0 | w=27
  301. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:realgar-indigo naturalis formulation
    n1=en:cd47 antagonist alx148 | n2=en:realgar-indigo naturalis formulation | rel=r_associated | relid=0 | w=27
  302. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:retinoids
    n1=en:cd47 antagonist alx148 | n2=en:retinoids | rel=r_associated | relid=0 | w=27
  303. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:risperidone formulation in rumenic acid
    n1=en:cd47 antagonist alx148 | n2=en:risperidone formulation in rumenic acid | rel=r_associated | relid=0 | w=27
  304. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:siltuximab
    n1=en:cd47 antagonist alx148 | n2=en:siltuximab | rel=r_associated | relid=0 | w=27
  305. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:simtrazene
    n1=en:cd47 antagonist alx148 | n2=en:simtrazene | rel=r_associated | relid=0 | w=27
  306. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:thyrotropin alfa
    n1=en:cd47 antagonist alx148 | n2=en:thyrotropin alfa | rel=r_associated | relid=0 | w=27
  307. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:topoisomerase inhibitors
    n1=en:cd47 antagonist alx148 | n2=en:topoisomerase inhibitors | rel=r_associated | relid=0 | w=27
  308. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:vismodegib
    n1=en:cd47 antagonist alx148 | n2=en:vismodegib | rel=r_associated | relid=0 | w=27
  309. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:yangzheng xiaoji extract
    n1=en:cd47 antagonist alx148 | n2=en:yangzheng xiaoji extract | rel=r_associated | relid=0 | w=27
  310. en:cd47 antagonist alx148 -- r_associated #0: 27 / 0.628 -> en:zanolimumab
    n1=en:cd47 antagonist alx148 | n2=en:zanolimumab | rel=r_associated | relid=0 | w=27
  311. en:cd47 antagonist alx148 -- r_associated #0: 26 / 0.605 -> en:alectinib
    n1=en:cd47 antagonist alx148 | n2=en:alectinib | rel=r_associated | relid=0 | w=26
  312. en:cd47 antagonist alx148 -- r_associated #0: 26 / 0.605 -> en:alloxan
    n1=en:cd47 antagonist alx148 | n2=en:alloxan | rel=r_associated | relid=0 | w=26
  313. en:cd47 antagonist alx148 -- r_associated #0: 26 / 0.605 -> en:aminoglutethimide
    n1=en:cd47 antagonist alx148 | n2=en:aminoglutethimide | rel=r_associated | relid=0 | w=26
  314. en:cd47 antagonist alx148 -- r_associated #0: 26 / 0.605 -> en:antineoplastic immunomodulating agent
    n1=en:cd47 antagonist alx148 | n2=en:antineoplastic immunomodulating agent | rel=r_associated | relid=0 | w=26
  315. en:cd47 antagonist alx148 -- r_associated #0: 26 / 0.605 -> en:bcg vaccine
    n1=en:cd47 antagonist alx148 | n2=en:bcg vaccine | rel=r_associated | relid=0 | w=26
  316. en:cd47 antagonist alx148 -- r_associated #0: 26 / 0.605 -> en:bet inhibitor
    n1=en:cd47 antagonist alx148 | n2=en:bet inhibitor | rel=r_associated | relid=0 | w=26
  317. en:cd47 antagonist alx148 -- r_associated #0: 26 / 0.605 -> en:bexarotene
    n1=en:cd47 antagonist alx148 | n2=en:bexarotene | rel=r_associated | relid=0 | w=26
  318. en:cd47 antagonist alx148 -- r_associated #0: 26 / 0.605 -> en:camptothecin
    n1=en:cd47 antagonist alx148 | n2=en:camptothecin | rel=r_associated | relid=0 | w=26
  319. en:cd47 antagonist alx148 -- r_associated #0: 26 / 0.605 -> en:cyclophosphamide
    n1=en:cd47 antagonist alx148 | n2=en:cyclophosphamide | rel=r_associated | relid=0 | w=26
  320. en:cd47 antagonist alx148 -- r_associated #0: 26 / 0.605 -> en:cyproterone
    n1=en:cd47 antagonist alx148 | n2=en:cyproterone | rel=r_associated | relid=0 | w=26
  321. en:cd47 antagonist alx148 -- r_associated #0: 26 / 0.605 -> en:cytokine agent
    n1=en:cd47 antagonist alx148 | n2=en:cytokine agent | rel=r_associated | relid=0 | w=26
  322. en:cd47 antagonist alx148 -- r_associated #0: 26 / 0.605 -> en:dna binding agent
    n1=en:cd47 antagonist alx148 | n2=en:dna binding agent | rel=r_associated | relid=0 | w=26
  323. en:cd47 antagonist alx148 -- r_associated #0: 26 / 0.605 -> en:dopamine-somatostatin chimeric molecule bim-23a760
    n1=en:cd47 antagonist alx148 | n2=en:dopamine-somatostatin chimeric molecule bim-23a760 | rel=r_associated | relid=0 | w=26
  324. en:cd47 antagonist alx148 -- r_associated #0: 26 / 0.605 -> en:epipropidine
    n1=en:cd47 antagonist alx148 | n2=en:epipropidine | rel=r_associated | relid=0 | w=26
  325. en:cd47 antagonist alx148 -- r_associated #0: 26 / 0.605 -> en:glutathione disulfide nov-002
    n1=en:cd47 antagonist alx148 | n2=en:glutathione disulfide nov-002 | rel=r_associated | relid=0 | w=26
  326. en:cd47 antagonist alx148 -- r_associated #0: 26 / 0.605 -> en:hif-2alpha inhibitor pt2385
    n1=en:cd47 antagonist alx148 | n2=en:hif-2alpha inhibitor pt2385 | rel=r_associated | relid=0 | w=26
  327. en:cd47 antagonist alx148 -- r_associated #0: 26 / 0.605 -> en:ifosfamide
    n1=en:cd47 antagonist alx148 | n2=en:ifosfamide | rel=r_associated | relid=0 | w=26
  328. en:cd47 antagonist alx148 -- r_associated #0: 26 / 0.605 -> en:leuprolide
    n1=en:cd47 antagonist alx148 | n2=en:leuprolide | rel=r_associated | relid=0 | w=26
  329. en:cd47 antagonist alx148 -- r_associated #0: 26 / 0.605 -> en:lomustine
    n1=en:cd47 antagonist alx148 | n2=en:lomustine | rel=r_associated | relid=0 | w=26
  330. en:cd47 antagonist alx148 -- r_associated #0: 26 / 0.605 -> en:megestrol
    n1=en:cd47 antagonist alx148 | n2=en:megestrol | rel=r_associated | relid=0 | w=26
  331. en:cd47 antagonist alx148 -- r_associated #0: 26 / 0.605 -> en:mercuric cyanide
    n1=en:cd47 antagonist alx148 | n2=en:mercuric cyanide | rel=r_associated | relid=0 | w=26
  332. en:cd47 antagonist alx148 -- r_associated #0: 26 / 0.605 -> en:methoxyamine hydrochloride
    n1=en:cd47 antagonist alx148 | n2=en:methoxyamine hydrochloride | rel=r_associated | relid=0 | w=26
  333. en:cd47 antagonist alx148 -- r_associated #0: 26 / 0.605 -> en:monoclonal antibodies, antineoplastic
    n1=en:cd47 antagonist alx148 | n2=en:monoclonal antibodies, antineoplastic | rel=r_associated | relid=0 | w=26
  334. en:cd47 antagonist alx148 -- r_associated #0: 26 / 0.605 -> en:mycobacterial cell wall-dna complex
    n1=en:cd47 antagonist alx148 | n2=en:mycobacterial cell wall-dna complex | rel=r_associated | relid=0 | w=26
  335. en:cd47 antagonist alx148 -- r_associated #0: 26 / 0.605 -> en:n-phosphonacetyl-l-aspartate
    n1=en:cd47 antagonist alx148 | n2=en:n-phosphonacetyl-l-aspartate | rel=r_associated | relid=0 | w=26
  336. en:cd47 antagonist alx148 -- r_associated #0: 26 / 0.605 -> en:nutlin-3a
    n1=en:cd47 antagonist alx148 | n2=en:nutlin-3a | rel=r_associated | relid=0 | w=26
  337. en:cd47 antagonist alx148 -- r_associated #0: 26 / 0.605 -> en:opioid growth factor
    n1=en:cd47 antagonist alx148 | n2=en:opioid growth factor | rel=r_associated | relid=0 | w=26
  338. en:cd47 antagonist alx148 -- r_associated #0: 26 / 0.605 -> en:organic sulfone compound
    n1=en:cd47 antagonist alx148 | n2=en:organic sulfone compound | rel=r_associated | relid=0 | w=26
  339. en:cd47 antagonist alx148 -- r_associated #0: 26 / 0.605 -> en:ozone-based agent
    n1=en:cd47 antagonist alx148 | n2=en:ozone-based agent | rel=r_associated | relid=0 | w=26
  340. en:cd47 antagonist alx148 -- r_associated #0: 26 / 0.605 -> en:penberol
    n1=en:cd47 antagonist alx148 | n2=en:penberol | rel=r_associated | relid=0 | w=26
  341. en:cd47 antagonist alx148 -- r_associated #0: 26 / 0.605 -> en:phosphaplatin pt-112
    n1=en:cd47 antagonist alx148 | n2=en:phosphaplatin pt-112 | rel=r_associated | relid=0 | w=26
  342. en:cd47 antagonist alx148 -- r_associated #0: 26 / 0.605 -> en:piroxicam
    n1=en:cd47 antagonist alx148 | n2=en:piroxicam | rel=r_associated | relid=0 | w=26
  343. en:cd47 antagonist alx148 -- r_associated #0: 26 / 0.605 -> en:pol i inhibitor cx5461
    n1=en:cd47 antagonist alx148 | n2=en:pol i inhibitor cx5461 | rel=r_associated | relid=0 | w=26
  344. en:cd47 antagonist alx148 -- r_associated #0: 26 / 0.605 -> en:quinacrine dihydrochloride
    n1=en:cd47 antagonist alx148 | n2=en:quinacrine dihydrochloride | rel=r_associated | relid=0 | w=26
  345. en:cd47 antagonist alx148 -- r_associated #0: 26 / 0.605 -> en:ribosome-inactivating protein cy503
    n1=en:cd47 antagonist alx148 | n2=en:ribosome-inactivating protein cy503 | rel=r_associated | relid=0 | w=26
  346. en:cd47 antagonist alx148 -- r_associated #0: 26 / 0.605 -> en:ruthenium-based transferrin targeting agent nkp-1339
    n1=en:cd47 antagonist alx148 | n2=en:ruthenium-based transferrin targeting agent nkp-1339 | rel=r_associated | relid=0 | w=26
  347. en:cd47 antagonist alx148 -- r_associated #0: 26 / 0.605 -> en:tasisulam
    n1=en:cd47 antagonist alx148 | n2=en:tasisulam | rel=r_associated | relid=0 | w=26
  348. en:cd47 antagonist alx148 -- r_associated #0: 26 / 0.605 -> en:tgfbeta inhibitor ly3200882
    n1=en:cd47 antagonist alx148 | n2=en:tgfbeta inhibitor ly3200882 | rel=r_associated | relid=0 | w=26
  349. en:cd47 antagonist alx148 -- r_associated #0: 26 / 0.605 -> en:thiotepa
    n1=en:cd47 antagonist alx148 | n2=en:thiotepa | rel=r_associated | relid=0 | w=26
  350. en:cd47 antagonist alx148 -- r_associated #0: 20 / 0.465 -> en:epidermal growth factor receptor antagonist [epc]
    n1=en:cd47 antagonist alx148 | n2=en:epidermal growth factor receptor antagonist [epc] | rel=r_associated | relid=0 | w=20
  351. en:cd47 antagonist alx148 -- r_associated #0: 20 / 0.465 -> en:panobinostat lactate
    n1=en:cd47 antagonist alx148 | n2=en:panobinostat lactate | rel=r_associated | relid=0 | w=20
  352. en:cd47 antagonist alx148 -- r_associated #0: 20 / 0.465 -> inhibiteur de transduction du signal
    n1=en:cd47 antagonist alx148 | n2=inhibiteur de transduction du signal | rel=r_associated | relid=0 | w=20
  353. en:cd47 antagonist alx148 -- r_associated #0: 20 / 0.465 -> olaparib
    n1=en:cd47 antagonist alx148 | n2=olaparib | rel=r_associated | relid=0 | w=20
  354. en:cd47 antagonist alx148 -- r_associated #0: 20 / 0.465 -> ramucirumab
    n1=en:cd47 antagonist alx148 | n2=ramucirumab | rel=r_associated | relid=0 | w=20
  355. en:cd47 antagonist alx148 -- r_associated #0: 1 / 0.023 -> en:pharmacologic substance
    n1=en:cd47 antagonist alx148 | n2=en:pharmacologic substance | rel=r_associated | relid=0 | w=1
≈ 411 relations entrantes

  1. ramucirumab --- r_associated #0: 80 --> en:cd47 antagonist alx148
    n1=ramucirumab | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=80
  2. en:ramucirumab --- r_associated #0: 79 --> en:cd47 antagonist alx148
    n1=en:ramucirumab | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=79
  3. en:olaparib --- r_associated #0: 57 --> en:cd47 antagonist alx148
    n1=en:olaparib | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=57
  4. olaparib --- r_associated #0: 55 --> en:cd47 antagonist alx148
    n1=olaparib | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=55
  5. en:apoptotic pathway-targeting antineoplastic agent --- r_associated #0: 41 --> en:cd47 antagonist alx148
    n1=en:apoptotic pathway-targeting antineoplastic agent | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=41
  6. en:gallium maltolate --- r_associated #0: 35 --> en:cd47 antagonist alx148
    n1=en:gallium maltolate | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=35
  7. en:risperidone formulation in rumenic acid --- r_associated #0: 35 --> en:cd47 antagonist alx148
    n1=en:risperidone formulation in rumenic acid | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=35
  8. en:signal transduction inhibitor --- r_associated #0: 35 --> en:cd47 antagonist alx148
    n1=en:signal transduction inhibitor | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=35
  9. en:tgfbeta inhibitor ly3200882 --- r_associated #0: 35 --> en:cd47 antagonist alx148
    n1=en:tgfbeta inhibitor ly3200882 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=35
  10. inhibiteur de transduction du signal --- r_associated #0: 35 --> en:cd47 antagonist alx148
    n1=inhibiteur de transduction du signal | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=35
  11. en:prima-1 analog apr-246 --- r_associated #0: 34 --> en:cd47 antagonist alx148
    n1=en:prima-1 analog apr-246 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=34
  12. en:tigapotide --- r_associated #0: 34 --> en:cd47 antagonist alx148
    n1=en:tigapotide | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=34
  13. en:2-fluorofucose-containing sgn-2ff --- r_associated #0: 32 --> en:cd47 antagonist alx148
    n1=en:2-fluorofucose-containing sgn-2ff | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=32
  14. en:demethylating agent --- r_associated #0: 32 --> en:cd47 antagonist alx148
    n1=en:demethylating agent | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=32
  15. en:epidermal growth factor receptor antagonist [epc] --- r_associated #0: 32 --> en:cd47 antagonist alx148
    n1=en:epidermal growth factor receptor antagonist [epc] | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=32
  16. en:cell differentiating agent --- r_associated #0: 31 --> en:cd47 antagonist alx148
    n1=en:cell differentiating agent | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=31
  17. en:panobinostat lactate --- r_associated #0: 31 --> en:cd47 antagonist alx148
    n1=en:panobinostat lactate | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=31
  18. en:tyroserleutide --- r_associated #0: 30 --> en:cd47 antagonist alx148
    n1=en:tyroserleutide | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=30
  19. en:terfluranol --- r_associated #0: 29 --> en:cd47 antagonist alx148
    n1=en:terfluranol | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=29
  20. en:antineoplastic radiopharmaceutical agent --- r_associated #0: 28 --> en:cd47 antagonist alx148
    n1=en:antineoplastic radiopharmaceutical agent | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=28
  21. en:giracodazole --- r_associated #0: 28 --> en:cd47 antagonist alx148
    n1=en:giracodazole | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=28
  22. en:pol i inhibitor cx5461 --- r_associated #0: 28 --> en:cd47 antagonist alx148
    n1=en:pol i inhibitor cx5461 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=28
  23. en:antineoplastic protein inhibitor --- r_associated #0: 27 --> en:cd47 antagonist alx148
    n1=en:antineoplastic protein inhibitor | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=27
  24. en:nilandron --- r_associated #0: 27 --> en:cd47 antagonist alx148
    n1=en:nilandron | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=27
  25. en:amidino tic --- r_associated #0: 26 --> en:cd47 antagonist alx148
    n1=en:amidino tic | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=26
  26. en:hif-2alpha inhibitor pt2977 --- r_associated #0: 26 --> en:cd47 antagonist alx148
    n1=en:hif-2alpha inhibitor pt2977 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=26
  27. en:obatoclax --- r_associated #0: 26 --> en:cd47 antagonist alx148
    n1=en:obatoclax | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=26
  28. en:polyamine synthesis inhibitor --- r_associated #0: 26 --> en:cd47 antagonist alx148
    n1=en:polyamine synthesis inhibitor | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=26
  29. en:2-hydroxyoleic acid --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:2-hydroxyoleic acid | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  30. en:acivicin --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:acivicin | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  31. en:ad5-cmv-nis --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:ad5-cmv-nis | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  32. en:adenosine a3 receptor agonist cf102 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:adenosine a3 receptor agonist cf102 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  33. en:alectinib --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:alectinib | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  34. en:alemtuzumab --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:alemtuzumab | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  35. en:alkylating agents --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:alkylating agents | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  36. en:alloxan --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:alloxan | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  37. en:alpha-gal glycosphingolipids --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:alpha-gal glycosphingolipids | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  38. en:alvocidib hydrochloride --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:alvocidib hydrochloride | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  39. en:ambazone --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:ambazone | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  40. en:aminoglutethimide --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:aminoglutethimide | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  41. en:aminolevulinic acid --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:aminolevulinic acid | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  42. en:aminopterin --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:aminopterin | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  43. en:amsacrine --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:amsacrine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  44. en:androgen antagonists --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:androgen antagonists | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  45. en:angiogenesis inhibitor --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:angiogenesis inhibitor | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  46. en:anticarcinogenic agents --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:anticarcinogenic agents | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  47. en:antileukemic agent --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:antileukemic agent | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  48. en:antimetabolites --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:antimetabolites | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  49. en:antimetabolites, antineoplastic --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:antimetabolites, antineoplastic | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  50. en:antimetastatic agent --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:antimetastatic agent | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  51. en:antimitotic agents --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:antimitotic agents | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  52. en:antineoplastic adjuvants --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:antineoplastic adjuvants | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  53. en:antineoplastic agent combination sm-88 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:antineoplastic agent combination sm-88 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  54. en:antineoplastic agent trx-818 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:antineoplastic agent trx-818 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  55. en:antineoplastic agents, phytogenic --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:antineoplastic agents, phytogenic | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  56. en:antineoplastic alkaloid --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:antineoplastic alkaloid | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  57. en:antineoplastic alkylating agent --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:antineoplastic alkylating agent | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  58. en:antineoplastic anthraquinone --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:antineoplastic anthraquinone | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  59. en:antineoplastic antibiotic --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:antineoplastic antibiotic | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  60. en:antineoplastic biological agent --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:antineoplastic biological agent | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  61. en:antineoplastic hormonal/endocrine agent --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:antineoplastic hormonal/endocrine agent | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  62. en:antineoplastic hormones --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:antineoplastic hormones | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  63. en:antineoplastic immunomodulating agent --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:antineoplastic immunomodulating agent | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  64. en:antineoplastic metal complex agent --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:antineoplastic metal complex agent | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  65. en:antineoplastic metal complex preparation --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:antineoplastic metal complex preparation | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  66. en:antineoplastic vaccine --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:antineoplastic vaccine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  67. en:antineoplastic vinca alkaloid --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:antineoplastic vinca alkaloid | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  68. en:antineoplastics, other --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:antineoplastics, other | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  69. en:aromatase inhibitors --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:aromatase inhibitors | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  70. en:aromatase inhibitors, 3rd generation --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:aromatase inhibitors, 3rd generation | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  71. en:arsenic --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:arsenic | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  72. en:artemether sublingual spray --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:artemether sublingual spray | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  73. en:asp4132 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:asp4132 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  74. en:asp9853 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:asp9853 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  75. en:asparaginase --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:asparaginase | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  76. en:atezolizumab --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:atezolizumab | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  77. en:atr-101 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:atr-101 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  78. en:azacitidine --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:azacitidine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  79. en:azapicyl --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:azapicyl | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  80. en:azurin:50-77 cell penetrating peptide p28 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:azurin:50-77 cell penetrating peptide p28 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  81. en:bcg vaccine --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:bcg vaccine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  82. en:belinostat --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:belinostat | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  83. en:benaxibine --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:benaxibine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  84. en:bet inhibitor --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:bet inhibitor | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  85. en:beta-elemene --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:beta-elemene | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  86. en:beta-lapachone prodrug arq 761 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:beta-lapachone prodrug arq 761 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  87. en:bevacizumab --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:bevacizumab | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  88. en:bexarotene --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:bexarotene | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  89. en:bicalutamide --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:bicalutamide | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  90. en:biological response modifiers --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:biological response modifiers | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  91. en:birinapant --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:birinapant | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  92. en:blinatumomab --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:blinatumomab | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  93. en:braf inhibitor --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:braf inhibitor | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  94. en:breflate --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:breflate | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  95. en:brentuximab vedotin --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:brentuximab vedotin | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  96. en:bromacrylide --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:bromacrylide | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  97. en:bromodomain inhibitor abbv-075 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:bromodomain inhibitor abbv-075 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  98. en:bryostatin 1 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:bryostatin 1 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  99. en:budotitane --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:budotitane | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  100. en:busulfan --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:busulfan | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  101. en:bxq-350 nanovesicle formulation --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:bxq-350 nanovesicle formulation | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  102. en:cabozantinib --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:cabozantinib | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  103. en:calusterone --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:calusterone | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  104. en:camptothecin --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:camptothecin | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  105. en:cancell --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:cancell | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  106. en:cannabidiol --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:cannabidiol | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  107. en:carbohydrate processing inhibitor --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:carbohydrate processing inhibitor | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  108. en:carboxyamidotriazole orotate --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:carboxyamidotriazole orotate | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  109. en:caricotamide/tretazicar --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:caricotamide/tretazicar | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  110. en:carmustine --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:carmustine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  111. en:catumaxomab --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:catumaxomab | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  112. en:cd5789 cream --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:cd5789 cream | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  113. en:cedefingol --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:cedefingol | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  114. en:cephalostatin --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:cephalostatin | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  115. en:ceramide nanoliposome --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:ceramide nanoliposome | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  116. en:ceritinib --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:ceritinib | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  117. en:chemotherapeutic topical agent --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:chemotherapeutic topical agent | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  118. en:chlorambucil --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:chlorambucil | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  119. en:chlorotoxin [131i] --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:chlorotoxin [131i] | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  120. en:cinobufagin --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:cinobufagin | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  121. en:cisplatin --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:cisplatin | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  122. en:cisplatin/vinblastine/cell penetration enhancer formulation int230-6 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:cisplatin/vinblastine/cell penetration enhancer formulation int230-6 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  123. en:ck2-targeting synthetic peptide cigb-300 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:ck2-targeting synthetic peptide cigb-300 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  124. en:cladribine --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:cladribine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  125. en:clanfenur --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:clanfenur | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  126. en:compound kushen injection --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:compound kushen injection | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  127. en:ctrp agent terminology --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:ctrp agent terminology | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  128. en:ctrp terminology --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:ctrp terminology | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  129. en:cycle-phase nonspecific agent --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:cycle-phase nonspecific agent | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  130. en:cycle-phase specific agent --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:cycle-phase specific agent | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  131. en:cyclophosphamide --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:cyclophosphamide | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  132. en:cyproterone --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:cyproterone | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  133. en:cytokine agent --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:cytokine agent | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  134. en:cytoprotective agent --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:cytoprotective agent | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  135. en:cytostatic agents --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:cytostatic agents | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  136. en:cytotoxic agent --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:cytotoxic agent | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  137. en:dacarbazine --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:dacarbazine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  138. en:daratumumab --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:daratumumab | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  139. en:darinaparsin --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:darinaparsin | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  140. en:dexanabinol --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:dexanabinol | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  141. en:diarylsulfonylurea compound --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:diarylsulfonylurea compound | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  142. en:diethylstilbestrol --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:diethylstilbestrol | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  143. en:dihydrolenperone --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:dihydrolenperone | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  144. en:dimethyl sulfoxide --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:dimethyl sulfoxide | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  145. en:dna binding agent --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:dna binding agent | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  146. en:dna-rna transcription regulator --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:dna-rna transcription regulator | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  147. en:dopamine-somatostatin chimeric molecule bim-23a760 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:dopamine-somatostatin chimeric molecule bim-23a760 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  148. en:e-selectin antagonist gmi-1271 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:e-selectin antagonist gmi-1271 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  149. en:e2f1 pathway activator arq 171 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:e2f1 pathway activator arq 171 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  150. en:eflornithine --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:eflornithine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  151. en:elesclomol --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:elesclomol | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  152. en:elesclomol sodium --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:elesclomol sodium | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  153. en:elotuzumab --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:elotuzumab | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  154. en:enteric-coated trpm8 agonist d-3263 hydrochloride --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:enteric-coated trpm8 agonist d-3263 hydrochloride | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  155. en:enzalutamide --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:enzalutamide | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  156. en:enzyme inhibitors --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:enzyme inhibitors | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  157. en:ep4 receptor antagonist aat-007 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:ep4 receptor antagonist aat-007 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  158. en:epidermal growth factor receptor tyrosine kinase inhibitor --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:epidermal growth factor receptor tyrosine kinase inhibitor | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  159. en:epipropidine --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:epipropidine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  160. en:epothilones --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:epothilones | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  161. en:erastin analogue prlx 93936 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:erastin analogue prlx 93936 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  162. en:erythrocyte-encapsulated l-asparaginase suspension --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:erythrocyte-encapsulated l-asparaginase suspension | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  163. en:estrogen antagonists --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:estrogen antagonists | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  164. en:etidronate-cytarabine conjugate mbc-11 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:etidronate-cytarabine conjugate mbc-11 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  165. en:etoposide --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:etoposide | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  166. en:ets-family transcription factor inhibitor tk216 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:ets-family transcription factor inhibitor tk216 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  167. en:everolimus --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:everolimus | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  168. en:fact complex-targeting curaxin cbl0137 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:fact complex-targeting curaxin cbl0137 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  169. en:factor viia inhibitor pci-27483 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:factor viia inhibitor pci-27483 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  170. en:fazarabine --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:fazarabine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  171. en:fenretinide --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:fenretinide | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  172. en:fermented soybean protein beverage --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:fermented soybean protein beverage | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  173. en:finasteride --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:finasteride | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  174. en:floxuridine --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:floxuridine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  175. en:fludarabine --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:fludarabine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  176. en:fluorouracil --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:fluorouracil | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  177. en:flutamide --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:flutamide | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  178. en:folate receptor-targeted vinca alkaloid/mitomycin c ec0225 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:folate receptor-targeted vinca alkaloid/mitomycin c ec0225 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  179. en:forodesine --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:forodesine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  180. en:fosquidone --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:fosquidone | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  181. en:galectin inhibitor gr-md-02 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:galectin inhibitor gr-md-02 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  182. en:gallium nitrate --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:gallium nitrate | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  183. en:gamboge resin extract tsb-9-w1 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:gamboge resin extract tsb-9-w1 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  184. en:gemcitabine --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:gemcitabine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  185. en:gemtuzumab ozogamicin --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:gemtuzumab ozogamicin | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  186. en:glucocorticoid receptor antagonist cort125134 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:glucocorticoid receptor antagonist cort125134 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  187. en:glutathione disulfide nov-002 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:glutathione disulfide nov-002 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  188. en:hafnium oxide-containing nanoparticles nbtxr3 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:hafnium oxide-containing nanoparticles nbtxr3 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  189. en:harringtonines --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:harringtonines | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  190. en:heat shock protein inhibitor --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:heat shock protein inhibitor | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  191. en:heparan sulfate glycosaminoglycan mimetic m402 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:heparan sulfate glycosaminoglycan mimetic m402 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  192. en:hif-1alpha inhibitor px-478 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:hif-1alpha inhibitor px-478 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  193. en:hif-2alpha inhibitor pt2385 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:hif-2alpha inhibitor pt2385 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  194. en:huachansu --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:huachansu | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  195. en:huaier extract granule --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:huaier extract granule | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  196. en:hydroxyurea --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:hydroxyurea | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  197. en:hypoxia-activated prodrug th-302 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:hypoxia-activated prodrug th-302 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  198. en:ibritumomab --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:ibritumomab | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  199. en:ibritumomab tiuxetan --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:ibritumomab tiuxetan | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  200. en:idasanutlin --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:idasanutlin | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  201. en:idelalisib --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:idelalisib | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  202. en:ifosfamide --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:ifosfamide | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  203. en:imiquimod --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:imiquimod | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  204. en:ingenol mebutate --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:ingenol mebutate | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  205. en:ingenol mebutate gel --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:ingenol mebutate gel | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  206. en:inproquone --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:inproquone | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  207. en:intiquinatine --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:intiquinatine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  208. en:intravesical bcg --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:intravesical bcg | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  209. en:ipilimumab --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:ipilimumab | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  210. en:irinotecan --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:irinotecan | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  211. en:jin fu kang --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:jin fu kang | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  212. en:kanglaite --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:kanglaite | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  213. en:lactoferrin-derived lytic peptide ltx-315 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:lactoferrin-derived lytic peptide ltx-315 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  214. en:lapachone --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:lapachone | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  215. en:lenalidomide --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:lenalidomide | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  216. en:leuprolide --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:leuprolide | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  217. en:lipid encapsulated anti-plk1 sirna tkm-plk1 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:lipid encapsulated anti-plk1 sirna tkm-plk1 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  218. en:liposome-encapsulated mir-34 mimic mrx34 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:liposome-encapsulated mir-34 mimic mrx34 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  219. en:liver x receptor beta agonist rgx-104 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:liver x receptor beta agonist rgx-104 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  220. en:lomustine --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:lomustine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  221. en:lysine-specific demethylase 1 inhibitor incb059872 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:lysine-specific demethylase 1 inhibitor incb059872 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  222. en:maltose tetrapalmitate --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:maltose tetrapalmitate | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  223. en:mcl-1 inhibitor amg 176 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:mcl-1 inhibitor amg 176 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  224. en:mcl-1 inhibitor mik665 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:mcl-1 inhibitor mik665 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  225. en:mechlorethamine --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:mechlorethamine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  226. en:megestrol --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:megestrol | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  227. en:melphalan --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:melphalan | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  228. en:mercuric cyanide --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:mercuric cyanide | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  229. en:metaiodobenzylguanidine[131i] --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:metaiodobenzylguanidine[131i] | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  230. en:methotrexate --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:methotrexate | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  231. en:methoxyamine --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:methoxyamine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  232. en:methoxyamine hydrochloride --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:methoxyamine hydrochloride | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  233. en:miltefosine --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:miltefosine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  234. en:mipsagargin --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:mipsagargin | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  235. en:mitoquidone --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:mitoquidone | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  236. en:mitoxantrone --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:mitoxantrone | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  237. en:modified vitamin d binding protein macrophage activator ef-022 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:modified vitamin d binding protein macrophage activator ef-022 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  238. en:molecular target inhibitors --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:molecular target inhibitors | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  239. en:monocarboxylate transporter 1 inhibitor azd3965 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:monocarboxylate transporter 1 inhibitor azd3965 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  240. en:monoclonal antibodies, antineoplastic --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:monoclonal antibodies, antineoplastic | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  241. en:morinda citrifolia extract --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:morinda citrifolia extract | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  242. en:mouse renal adenocarcinoma cell-encapsulated agarose-agarose macrobeads --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:mouse renal adenocarcinoma cell-encapsulated agarose-agarose macrobeads | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  243. en:mutant p53 activator coti-2 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:mutant p53 activator coti-2 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  244. en:mycobacterial cell wall-dna complex --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:mycobacterial cell wall-dna complex | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  245. en:myeloablative agonist --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:myeloablative agonist | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  246. en:n-phosphonacetyl-l-aspartate --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:n-phosphonacetyl-l-aspartate | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  247. en:nanocell-encapsulated mir-16-based microrna mimic --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:nanocell-encapsulated mir-16-based microrna mimic | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  248. en:napabucasin --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:napabucasin | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  249. en:naptumomab --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:naptumomab | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  250. en:ncit antineoplastic agent terminology --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:ncit antineoplastic agent terminology | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  251. en:nintedanib --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:nintedanib | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  252. en:nutlin-3a --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:nutlin-3a | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  253. en:oblimersen --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:oblimersen | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  254. en:oleandrin --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:oleandrin | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  255. en:opioid growth factor --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:opioid growth factor | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  256. en:oregovomab --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:oregovomab | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  257. en:organic sulfone compound --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:organic sulfone compound | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  258. en:oxphos inhibitor vlx600 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:oxphos inhibitor vlx600 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  259. en:ozone-based agent --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:ozone-based agent | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  260. en:p-cadherin antagonist pf-03732010 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:p-cadherin antagonist pf-03732010 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  261. en:p-cadherin inhibitor pca062 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:p-cadherin inhibitor pca062 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  262. en:p-cadherin-targeting agent pf-06671008 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:p-cadherin-targeting agent pf-06671008 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  263. en:p53-hdm2 interaction inhibitor mi-773 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:p53-hdm2 interaction inhibitor mi-773 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  264. en:p53-hdm2 protein-protein interaction inhibitor apg-115 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:p53-hdm2 protein-protein interaction inhibitor apg-115 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  265. en:p53/hdm2 interaction inhibitor cgm097 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:p53/hdm2 interaction inhibitor cgm097 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  266. en:paclitaxel --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:paclitaxel | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  267. en:palbociclib --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:palbociclib | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  268. en:panobinostat --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:panobinostat | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  269. en:pegylated human recombinant arginase 1 aeb1102 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:pegylated human recombinant arginase 1 aeb1102 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  270. en:pegylated recombinant l-asparaginase erwinia chrysanthemi --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:pegylated recombinant l-asparaginase erwinia chrysanthemi | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  271. en:pembrolizumab --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:pembrolizumab | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  272. en:penberol --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:penberol | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  273. en:pertuzumab --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:pertuzumab | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  274. en:phosphaplatin pt-112 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:phosphaplatin pt-112 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  275. en:photosensitizing agent --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:photosensitizing agent | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  276. en:piroxicam --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:piroxicam | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  277. en:pleiotropic pathway modifier cc-122 hydrochloride --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:pleiotropic pathway modifier cc-122 hydrochloride | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  278. en:plenaxis --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:plenaxis | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  279. en:plevitrexed --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:plevitrexed | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  280. en:poly(adp-ribose) polymerase inhibitors --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:poly(adp-ribose) polymerase inhibitors | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  281. en:polyamine analogue --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:polyamine analogue | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  282. en:pomalidomide --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:pomalidomide | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  283. en:pr-104 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:pr-104 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  284. en:proapoptotic sulindac analog cp-461 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:proapoptotic sulindac analog cp-461 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  285. en:procarbazine --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:procarbazine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  286. en:procaspase activating compound-1 vo-100 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:procaspase activating compound-1 vo-100 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  287. en:proteasome inhibitor --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:proteasome inhibitor | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  288. en:protective agents --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:protective agents | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  289. en:pv-10 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:pv-10 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  290. en:pyridyl cyanoguanidine chs 828 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:pyridyl cyanoguanidine chs 828 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  291. en:quarfloxin --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:quarfloxin | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  292. en:quinacrine dihydrochloride --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:quinacrine dihydrochloride | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  293. en:radiosensitizing agent --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:radiosensitizing agent | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  294. en:razoxane --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:razoxane | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  295. en:realgar-indigo naturalis formulation --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:realgar-indigo naturalis formulation | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  296. en:recombinant ephb4-hsa fusion protein --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:recombinant ephb4-hsa fusion protein | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  297. en:retinoids --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:retinoids | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  298. en:ribosome-inactivating protein cy503 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:ribosome-inactivating protein cy503 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  299. en:rituximab --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:rituximab | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  300. en:ruthenium-based transferrin targeting agent nkp-1339 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:ruthenium-based transferrin targeting agent nkp-1339 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  301. en:ruxolitinib --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:ruxolitinib | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  302. en:samarium sm 153 lexidronam --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:samarium sm 153 lexidronam | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  303. en:selective estrogen receptor modulators --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:selective estrogen receptor modulators | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  304. en:selinexor --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:selinexor | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  305. en:siltuximab --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:siltuximab | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  306. en:simtrazene --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:simtrazene | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  307. en:sodium borocaptate --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:sodium borocaptate | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  308. en:sodium dichloroacetate --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:sodium dichloroacetate | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  309. en:splicing inhibitor h3b-8800 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:splicing inhibitor h3b-8800 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  310. en:sr-t100 gel --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:sr-t100 gel | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  311. en:streptozocin --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:streptozocin | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  312. en:synthesis inhibitors, dna --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:synthesis inhibitors, dna | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  313. en:synthetic antiandrogen --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:synthetic antiandrogen | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  314. en:synthetic antiestrogen --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:synthetic antiestrogen | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  315. en:talimogene laherparepvec --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:talimogene laherparepvec | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  316. en:tasisulam --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:tasisulam | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  317. en:tasisulam sodium --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:tasisulam sodium | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  318. en:taurultam --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:taurultam | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  319. en:tazemetostat --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:tazemetostat | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  320. en:teglarinad --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:teglarinad | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  321. en:teglarinad chloride --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:teglarinad chloride | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  322. en:temozolomide --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:temozolomide | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  323. en:temsirolimus --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:temsirolimus | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  324. en:testolactone --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:testolactone | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  325. en:thioguanine --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:thioguanine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  326. en:thiotepa --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:thiotepa | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  327. en:thioureidobutyronitrile --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:thioureidobutyronitrile | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  328. en:thyrotropin alfa --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:thyrotropin alfa | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  329. en:tilorone --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:tilorone | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  330. en:tirapazamine --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:tirapazamine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  331. en:tolnidamine --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:tolnidamine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  332. en:topical betulinic acid --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:topical betulinic acid | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  333. en:topoisomerase ii inhibitors --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:topoisomerase ii inhibitors | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  334. en:topoisomerase inhibitors --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:topoisomerase inhibitors | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  335. en:topsalysin --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:topsalysin | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  336. en:tositumomab --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:tositumomab | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  337. en:trastuzumab --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:trastuzumab | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  338. en:tretazicar --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:tretazicar | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  339. en:trimetrexate --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:trimetrexate | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  340. en:triptorelin --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:triptorelin | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  341. en:trpv6 calcium channel inhibitor sor-c13 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:trpv6 calcium channel inhibitor sor-c13 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  342. en:urethane --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:urethane | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  343. en:venetoclax --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:venetoclax | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  344. en:verteporfin --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:verteporfin | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  345. en:vinblastine --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:vinblastine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  346. en:vinca alkaloids --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:vinca alkaloids | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  347. en:vincristine --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:vincristine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  348. en:vismodegib --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:vismodegib | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  349. en:vorinostat --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:vorinostat | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  350. en:xanthohumol --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:xanthohumol | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  351. en:yangzheng xiaoji extract --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:yangzheng xiaoji extract | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  352. en:zanolimumab --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:zanolimumab | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  353. en:zinc finger nuclease zfn-603 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:zinc finger nuclease zfn-603 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  354. en:zinc finger nuclease zfn-758 --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=en:zinc finger nuclease zfn-758 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  355. uréthane --- r_associated #0: 20 --> en:cd47 antagonist alx148
    n1=uréthane | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=20
  356. agoniste du récepteur A3 de l'adénosine CF102 --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=agoniste du récepteur A3 de l'adénosine CF102 | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  357. alemtuzumab --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=alemtuzumab | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  358. antimétabolites --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=antimétabolites | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  359. asparaginase --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=asparaginase | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  360. bevacizumab --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=bevacizumab | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  361. blinatumomab --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=blinatumomab | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  362. busulfan --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=busulfan | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  363. camptothécine --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=camptothécine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  364. cannabidiol --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=cannabidiol | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  365. carmustine --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=carmustine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  366. ceritinib --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=ceritinib | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  367. chlorambucil --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=chlorambucil | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  368. cis-diaminedichloroplatine --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=cis-diaminedichloroplatine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  369. cisplatine --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=cisplatine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  370. composé organique de sulfone --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=composé organique de sulfone | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  371. cyclophosphamide --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=cyclophosphamide | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  372. cyprotérone --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=cyprotérone | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  373. dacarbazine --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=dacarbazine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  374. daratumumab --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=daratumumab | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  375. enzalutamide --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=enzalutamide | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  376. floxuridine --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=floxuridine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  377. fludarabine --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=fludarabine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  378. fluorouracile --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=fluorouracile | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  379. flutamide --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=flutamide | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  380. gemcitabine --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=gemcitabine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  381. ifosfamide --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=ifosfamide | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  382. imiquimod --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=imiquimod | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  383. ipilimumab --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=ipilimumab | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  384. irinotecan --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=irinotecan | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  385. lomustine --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=lomustine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  386. melphalan --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=melphalan | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  387. mitoxantrone --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=mitoxantrone | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  388. méthotrexate --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=méthotrexate | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  389. oléandrine --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=oléandrine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  390. palbociclib --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=palbociclib | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  391. pembrolizumab --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=pembrolizumab | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  392. pertuzumab --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=pertuzumab | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  393. piroxicam --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=piroxicam | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  394. procarbazine --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=procarbazine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  395. ruxolitinib --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=ruxolitinib | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  396. siltuximab --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=siltuximab | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  397. thioguanine --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=thioguanine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  398. vinblastine --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=vinblastine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  399. vincristine --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=vincristine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  400. éflornithine --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=éflornithine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  401. épothilones --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=épothilones | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  402. étoposide --- r_associated #0: 10 --> en:cd47 antagonist alx148
    n1=étoposide | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  403. alloxane --- r_associated #0: 5 --> en:cd47 antagonist alx148
    n1=alloxane | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=5
  404. cladribine --- r_associated #0: 5 --> en:cd47 antagonist alx148
    n1=cladribine | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=5
  405. cyanure de mercure --- r_associated #0: 5 --> en:cd47 antagonist alx148
    n1=cyanure de mercure | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=5
  406. diéthylstilbestrol --- r_associated #0: 5 --> en:cd47 antagonist alx148
    n1=diéthylstilbestrol | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=5
  407. en:sarcolysin --- r_associated #0: 5 --> en:cd47 antagonist alx148
    n1=en:sarcolysin | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=5
  408. finastéride --- r_associated #0: 5 --> en:cd47 antagonist alx148
    n1=finastéride | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=5
  409. hormones antinéoplasiques --- r_associated #0: 5 --> en:cd47 antagonist alx148
    n1=hormones antinéoplasiques | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=5
  410. rituximab --- r_associated #0: 5 --> en:cd47 antagonist alx148
    n1=rituximab | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=5
  411. thyrotropine alfa --- r_associated #0: 5 --> en:cd47 antagonist alx148
    n1=thyrotropine alfa | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr